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Dedicated to all those who participated in these studies, 
by courageously struggling with anxiety and depression. 
 ABSTRACT 
 
Major depression (MD) and panic disorder (PD) are two common disorders for which 
evidence based psychological treatments such as cognitive behaviour therapy (CBT) 
have been developed. The accessibility of such treatment is however limited. The use 
of Internet-based CBT (self-help programmes accompanied by brief therapist support 
by e-mail) is a promising way to increase accessibility. 
The first aim of this thesis was to investigate if Internet treatment was effective 
in reducing depressive symptoms and if it was possible to predict which participants 
would benefit from such treatment. The second aim of the thesis was to investigate if 
Internet treatment was effective for PD patients in a regular care setting, in comparison 
with traditional group-administered CBT, and in addition, to compare the cost-
effectiveness of the two treatments. 
In Study I 85 participants were randomised to either an Internet treatment or to 
an attention control condition (an online discussion group). Post-treatment measures of 
depression showed large effect sizes and improvements were sustained at a 6-month 
follow-up, thus showing that Internet treatment was effective in reducing mild to 
moderate symptoms of depression. Study II analysed predictors of treatment outcome 
at the 6-month follow-up of Study I. Higher self-reported severity at baseline was 
associated with poorer outcome and a negative correlation was found between number 
of previous episodes of depression and improvement in treatment. 
Study III was an open effectiveness trial evaluating Internet treatment, which in 
previous studies had been shown to be effective with self-recruited participants, within 
a regular psychiatric setting for 20 PD patients referred for treatment. After treatment 
75% of patients were considered to have responded to treatment, and at the 6-month 
follow-up this proportion was 70%, indicating that this treatment form was transferable 
to a regular care setting with sustained effectiveness. 
Study IV was a randomised clinical trial comparing Internet- and group-
administered CBT for PD with 104 patients in a psychiatric setting. Both treatments 
produced significant improvements, and there were no statistically significant 
differences between them at post-treatment or at the 6-month follow up. A cost-
effectiveness analysis showed that the Internet treatment was more cost-effective than 
the group treatment with regard to therapist time. 
This thesis provides evidence that Internet treatment is effective in reducing 
symptoms of depression and of PD. Internet treatment is as effective as traditionally 
administered group CBT in a regular care setting with PD patients referred for 
treatment. The thesis also provides evidence that Internet treatment for PD is more 
cost-effective than group treatment. Taken together, the results support the 
implementation of Internet treatment for depression and PD within regular health care 
settings. 
 
Keywords: depression, panic disorder, agoraphobia, cognitive behaviour therapy, self-
help, bibliotherapy, Internet, effectiveness, cost-effectiveness 
 RÉSUMÉ 
 
La dépression majeure (DM) et le trouble panique (TP) sont deux troubles pour 
lesquels des traitements psychologiques efficaces ont été développés, comme la 
thérapie comportementale et cognitive (TCC). L’accès à un tel traitement est cependant 
limité. L’usage de la TCC par Internet (des programmes « self-help » accompagnés 
d’un bref soutien thérapeutique par courriel) est un moyen prometteur pour augmenter 
l’accessibilité du traitement. 
Le premier objectif de cette thèse était d’examiner si le traitement par Internet 
était efficace pour réduire des symptômes dépressifs et s’il était possible de prédire 
quels participants allaient bénéficier d’un tel traitement. Le deuxième objectif de la 
thèse était, d’une part, d’examiner si le traitement par Internet était efficace pour des 
patients avec un TP dans un milieu de soins réguliers, en comparaison avec un 
traitement TCC traditionnel en groupe et, d’autre part, d’examiner le coût-efficacité des 
deux traitements. 
Dans l’Etude I, 85 participants ont été répartis par randomisation entre un 
traitement par Internet et une condition de contrôle d’attention (un forum de 
discussion). Des mesures de dépression post traitement ont montré des tailles d’effet 
larges et cette amélioration était maintenue dans les mesures lors du suivi de 6 mois, 
montrant donc que le traitement par Internet était efficace pour réduire des symptômes 
dépressifs. L’Etude II a analysé des prédicteurs du résultat du traitement au suivi de 6 
mois de l’Etude I. Le niveau de symptômes dépressifs prétraitement et le nombre 
d’épisodes de dépression antérieurs étaient associés à une amélioration moins 
importante. 
L’Etude III était un essai ouvert évaluant un traitement par Internet, ayant 
montré son efficacité avec des participants volontaires dans des études précédentes, 
dans un milieu de soins psychiatriques réguliers et pour 20 patients avec un TP adressés 
pour traitement. Lors des mesures post traitement 75% des patients étaient considérés 
comme ayant une bonne réponse au traitement et la proportion était de 70% lors du 
suivi de 6 mois, indiquant ainsi qu’il était possible de transférer ce traitement dans un 
milieu de soins réguliers tout en conservant son efficacité. 
L’Etude IV était un essai randomisé contrôlé comparant l’efficacité de la TCC 
administrée soit par Internet soit en groupe, pour 104 patients dans un milieu de soins 
psychiatriques. Les deux traitements ont produit des améliorations significatives, et il 
n’y avait pas de différences statistiquement significatives ni lors des mesures post 
traitement ni lors du suivi de 6 mois. Une analyse coût-efficacité a montré que le 
traitement par Internet était plus coût-efficace que le traitement en groupe en ce qui 
concerne le temps employé par les thérapeutes.  
Cette thèse fournit des preuves de l’efficacité du traitement par Internet dans la 
réduction des symptômes de dépression et de TP, et que ce traitement est aussi efficace 
que la TCC en groupe pour des patients adressés pour traitement dans un milieu de 
soins réguliers. Elle fournit aussi des preuves que le traitement par Internet du TP est 
davantage coût-efficace que le traitement en groupe. En somme, les résultats 
soutiennent une implémentation du traitement par Internet pour la dépression et le TP 
dans le milieu de soins réguliers.  
 
Mots clés : dépression, trouble panique, agoraphobie, thérapie comportementale et 
cognitive, self-help, bibliothérapie, Internet, coût-efficacité. 
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1 INTRODUCTION 
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1.1 BACKGROUND 
Fear, worry and low mood are experiences we all are familiar with and which seem to 
be inevitable parts of life. For some people however, less fortunate then others, these 
experiences are not merely episodes of temporary discomfort but rather something that 
permeates their life altogether. 
 
“Everything that could have been a source of compassion, of lust […] has become a 
source of suffering and despair. Since several years I have walked side by side with a 
phantom that resembles me, who lives in a theoretical paradise, in close relation to the 
world. I have for a long time believed that I was to reunite with him. That is now all over. 
[…] The sense of separation is complete, I am hereafter a prisoner in myself.” 
(Houellebecq, 1994) 
 
When this happens, that is, when normal transient experience turns into debilitating 
suffering and hinders functioning in daily life, we talk of psychiatric diagnoses. 
 
Major depression (MD) and anxiety disorders are, along with substance abuse and 
impulse-control disorders, the most common forms of psychiatric illness we know, 
affecting around 16-17 % and 24-28 % respectively of the adult population in their 
lifetime (Kessler, Berglund, et al., 2005; Kessler, et al., 1994). The World Health 
Organization (2002) noted that MD is one of the disorders with the highest disease 
burden in the world, projected to be the second leading cause of disability worldwide 
(after heart disease) in 2020 (Murray & Lopez, 1997). 
 
Much effort has been put into trying to diminish the burden of these psychiatric 
disorders, and two of the most promising developments are the pharmacological 
treatments known as antidepressants (Arroll, et al., 2009; Cipriani, et al., 2009) and the 
psychological treatments known as CBTs (cognitive behavioural therapies) (Cuijpers, 
van Straten, Andersson, & van Oppen, 2008; Norton & Price, 2007). 
 
However, whereas access to pharmacological treatment can be said to be relatively 
satisfactory, access to evidence-based psychological treatments is still a problem 
(Richards, Lovell, & McEvoy, 2003). Since patients tend to prefer one or the other 
treatment and preferences can influence outcome it is important that health care can 
deliver all evidence-based treatments, in particular for patients who for various reasons 
can not tolerate one particular treatment (e.g., medication).  
 
In response to this a field of research has emerged which attempts to find ways to make 
CBT more accessible. This has been done by increasing the patient’s own involvement 
in therapy, notably by different forms of psychological self-help approaches, in which 
the amount of therapist contact is reduced (den Boer, Wiersma, & Van den Bosch, 
2004). Internet-based CBT is such a development that for the last ten years has been 
found to be an efficacious treatment alternative in research studies (Andersson, 2009; 
Spek, Cuijpers, et al., 2007), with the potential to increase access to evidence-based 
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psychological treatments. A number of trials have been conducted evaluating Internet-
based CBT for depression and panic disorder (PD). However, it has been unclear how 
Internet treatment works in regular psychiatric health care settings, with referred 
patients, and which factors that are important for treatment response. 
 
This doctoral thesis describes the development of Internet-based CBT for depression 
and PD and the deployment of this treatment form within regular psychiatric health 
care. By doing so, it wishes to contribute to the important endeavour of making 
effective psychological treatments more accessible for those in great need of them. 
 
 6 
1.2 PANIC DISORDER AND DEPRESSION 
1.2.1 Diagnosis of panic disorder 
Panic has been a well known condition in the medical literature for a very long time, 
with the first documentation dating from the late 19th century (Benedikt, 1870). In the 
dominant diagnostic system of our time, the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) (American Psychiatric Association, 2000a), PD is defined by 
its central feature, the panic attack (PA). The DSM-IV defines a PA as a “discrete 
period of intense fear or discomfort in the absence of real danger” that should arise 
abruptly and reach its peek within 10 minutes. The DSM-IV lists 13 characteristic 
symptoms of such an attack and says that at least 4 of them must be present for it to 
qualify as a full panic attack: 1. Palpitations, pounding heart, or accelerated heart rate, 
2. Sweating, 3. Trembling or shaking, 4. Sensations of shortness of breath or 
smothering, 5. Feeling of choking, 6. Chest pain or chest discomfort, 7. Nausea or 
abdominal distress, 8. Feeling dizzy, unsteady, lightheaded, or faint, 9. Derealisation or 
depersonalization, 10. Fear of losing control or going crazy, 11. Fear of dying, 12. 
Paresthesias (numbness or tingling sensations), 13. Chills or hot flushes. 
 
While being the essential symptom of the disorder, the presence of PAs is not exclusive 
to PD. Indeed, there is probably no psychiatric disorder where PAs do not occasionally 
occur as a part of a period of elevated anxiety (Goodwin, 2003). For the DSM-IV 
diagnosis of PD to be made, at least one of the attacks has to be followed by one month 
(or more) of at least one of these symptoms: 1. Persistent concern about having 
additional attacks, 2. Worry about the implications of the attack or its consequences, 3. 
A significant change in behaviour related to the attacks. What emerges after the initial 
attack(s) is in other words a strong fear of what will happen the next time (e.g. having a 
stroke, heart attack, or “going crazy”) and that the person tries to avoid the situations 
where the attack(s) took place, in order to prevent this catastrophic outcome. 
 
This latter feature of the disorder, avoidant behaviour, often develops into 
agoraphobia. The DSM-IV defines agoraphobia as “Anxiety about being in places or 
situations from which escape might be difficult (or embarrassing) or in which help may 
not be available in the event of having an unexpected or situationally predisposed PA 
or panic-like symptoms” and that “The situations are avoided […] or else are endured 
with marked distress or with anxiety about having a PA or panic-like symptoms, or 
require the presence of a companion”. Typical agoraphobic situations are public 
transport, closed places (elevators, bathrooms etc.), supermarkets, or, often in more 
severe cases, simply being alone. A recurrent finding is that among PD patients, 
comorbid agoraphobia is associated with higher severity, impairment, and other 
comorbidity (Batelaan, et al., 2010; Kessler, et al., 2006), as well as lower rates of 
recovery over time (Bruce, et al., 2005) 
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Since the DSM-III-R (American Psychiatric Association, 1987) this diagnostic system 
only includes the diagnosis of PD with agoraphobia (PDA), PD without agoraphobia 
(PDWA), and agoraphobia without history of PD. That is, agoraphobia has not been 
viewed as a discrete disorder but only diagnosed in relation to PD. This is however 
inconsistent with research on agoraphobia, which suggests that it is best viewed as a 
separate diagnosis (Bienvenu, et al., 2006; Wittchen, et al., 2008). The origin of such 
“pure” agoraphobia can for example be fear of urinary or faecal soiling or vomiting in a 
public space, with no subjective experience of panic-like symptoms. The research on 
agoraphobia also suggests that it is potentially just as debilitating as PD. In the 
upcoming DSM-V, agoraphobia is therefore proposed to become a discrete, 
independent diagnosis (American Psychiatric Association, 2010a). As a consequence, 
in the DSM-V, the diagnoses of PDA and PDWA are proposed to disappear, leaving 
the sole diagnosis of PD (American Psychiatric Association, 2010c), which thus can be 
comorbid or not with agoraphobia.  
 
The diagnostic confusion surrounding agoraphobia that came with the DSM-III and the 
primary role that then was given to PAs (Ramnerö & Öst, 2007) is probably the reason 
for the weakening research interest in agoraphobia since the 1980s (Boschen, 2008). In 
contrast, research on panic has increased during this period of time. 
1.2.2 Diagnosis of depression 
Even if known under different names throughout human history, the first to describe 
depression1 in the medical literature was the German psychiatrist Emil Kraepelin who 
in the early 20th century distinguished what he called “involutional melancholia” from 
the previously described manic-depressive psychosis (Hirshbein, 2006). Since then, 
much has changed in research and nosology, leading up to what we today call major 
depressive disorder (MDD). However, the term “melancholia” has been used since 
much earlier, and at least since the 17th century, for what we today probably would call 
depression.  
 
If the PA is the central feature in PD, the major depressive episode (MDE) is certainly 
the main feature of MDD in the DSM-IV (American Psychiatric Association, 2000a). 
The DSM-IV lists 9 common depressive symptoms and defines a MDE as a “two-week 
period [ that represents ] a change from previous functioning” including at least 5 of the 
9 symptoms (criterion A). All these symptoms (except the last, 9.) are defined as 
having to be present “nearly every day”. DSM-IV also specifies that at least one of the 
two primary symptoms (listed first) must be present for the diagnosis to be made. The 
nine depressive symptoms are: 1. Depressed mood most of the day, 2. Markedly 
diminished interest or pleasure in all, or almost all, activities most of the day, 3. 
Significant weight loss when not dieting or weight gain, 4. Insomnia or hypersomnia, 5. 
Psychomotor agitation or retardation, 6. Fatigue or loss of energy, 7. Feelings of 
worthlessness or excessive or inappropriate guilt, 8. Diminished ability to think or 
                                                
1 In this thesis the generic term “depression” will be used throughout the text as an 
generic term including MDD as well as sub-threshold depression and depressive 
symptoms. These individual terms will be then be made explicit when appropriate. 
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concentrate, or indecisiveness, 9. Recurrent thoughts of death (not just fear of dying), 
recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific 
plan for committing suicide. As with PA in PD, MDE is the central element in MDD, 
but does not solely suffice for this diagnosis to be made. In MDD, a MDE can be either 
single or recurrent (where at least two months have passed between discrete MDEs). 
One should also specify the severity of the MDE, if it is or not in remission, if it is 
chronic in nature, if it has catatonic or atypical features, or if it had postpartum onset. 
There is also the possibility to specify the course of the disorder, by specifying if there 
is an interepisode recovery or not, and whether there is a seasonal pattern. Following 
DSM-IV convention it is also said that “the symptoms cause clinically significant 
distress” (criterion C). 
 
As for the PD and agoraphobia diagnoses, there is however some controversy around 
the DSM-IV diagnosis of MDD. This line of criticism holds that the DSM-IV 
requirements for criterion A (two weeks duration and at least five symptoms) and 
clinically significant impairment (criterion C) have little empirical support for their use 
(Kendler & Gardner, 1998). It has been argued that depressive symptoms are best 
understood and described as continuous rather than dichotomous phenomena (Aggen, 
Neale, & Kendler, 2005). Therefore, there are empirical sound reasons behind the 
choice of the generic term “depression” in this thesis, as a categorical distinction 
between MDD, sub-threshold depression and depressive symptoms may not harmonise 
well with clinical reality. This point will be elaborated upon later when discussing the 
course of depression (1.2.5.2) and when discussing Study I. 
1.2.3 Differential diagnosis and comorbidity 
There is a well-documented and strong overlap between PD and MDD (Roy-Byrne, et 
al., 2000). About 50% of those suffering from PD and 73.3% of those with PDA have a 
comorbid mood disorder. More specifically, 34.7% and 38.5% respectively have 
comorbid MDD (Kessler, et al., 2006). In turn, 59.2% of those suffering from MDD 
have a comorbid anxiety disorder (Kessler, et al., 2003). In the DSM-V, a new 
diagnosis of Mixed Anxiety Depression is proposed as a free standing diagnosis 
(American Psychiatric Association, 2010b). Sleep disturbance is known to be highly 
aggravated by concomitant nocturnal panic attacks and depression (Singareddy & 
Uhde, 2009) 
 
PD and PDA have high comorbidity rates with other forms of anxiety as well (Kessler, 
et al., 2006). For example, 66% of PD patients and 93.6% of PDA patients have at least 
one other comorbid anxiety disorder. 
 
Important differential diagnostics to make among patients with suspected PD is 
hyperthyroidism and hypothyroidism (Simon, et al., 2002) as well as partial epileptic 
seizures without generalization, emanating from temporal lobe epilepsy (Deutsch, 
Rosse, Sud, & Burket, 2009; Hurley, Fisher, & Taber, 2006). Another more rare issue 
of differential diagnostics reported in the literature is that of temporal brain tumours 
(Kellner, Hirschmann, & Wiedemann, 1996).  
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1.2.4 Prevalence 
1.2.4.1 Panic disorder 
In the large and possibly most rigorous epidemiological study of prevalent psychiatric 
disorders, the American National Comorbidity Survey Replication (NCS-R), a life-time 
prevalence of 4.7% was found for PD with or without agoraphobia (Kessler, Berglund, 
et al., 2005). In a more specific analysis (Kessler, et al., 2006) the life time prevalence 
for PAs without agoraphobia was 22.7%, for PD without agoraphobia (PDWA) it was 
3.7%, and for PD with agoraphobia (PDA) it was 1.1%. Another large epidemiological 
study (Grant, et al., 2006) showed similar results for lifetime prevalence: 5.1% for PD 
(with or without agoraphobia), 4.0% for PDWA and 1.1%. for PDA. The rate of 
lifetime agoraphobia was considerably lower, at 0.17%.  
 
For 12-month prevalence, the NCS-R (Kessler, Chiu, Demler, Merikangas, & Walters, 
2005) reported a rate of 2.7% for PD (with or without agoraphobia), and for 
agoraphobia (without panic) 0.8%. In the study by Grant and colleges (2006) the 
reported 12-month prevalence was 2.1% for PD, 1.6% for PDWA, 0.6% for PDA, and 
0.05% for agoraphobia. 
 
Similar 12-month prevalence of PD is found in Europe, where it is estimated at 1.8% 
(Goodwin, et al., 2005). In a Swedish study (Carlbring, Gustafsson, Ekselius, & 
Andersson, 2002), the 12-month prevalence of PD was 2.2%.   
1.2.4.2 Depression 
There are considerable differences between reported prevalence rates of MDD around 
the world, ranging between 4% and 20% on rates of lifetime prevalence (Andrade, et 
al., 2003). It is very difficult to judge whether these differences reflect actual variation 
in rates of depressive illness or if they simply reflect the difficulties of defining 
depression recently evoked; that is if they result from different criteria used to establish 
diagnosis and from related methodological features of the studies that influence 
accuracy of the results obtained. 
 
In the NCS-R (Kessler, et al., 2003; Kessler, Berglund, et al., 2005) a life time 
prevalence of 16.6% was found for MDD, while the 12-month prevalence found 
(Kessler, Chiu, et al., 2005) was 6.7%. There are considerable sex differences in the 
prevalence MDD, with women having a life time prevalence of around 20% and men 
12% (Kessler, et al., 2003).  
1.2.5 Phenotype, onset and course 
1.2.5.1 Panic disorder 
The mean age of onset for PDWA and PDA has been estimated to be 23.6 years and 
22.9 years respectively (Kessler, et al., 2006). However, some data support that the age 
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onset has a bimodal distribution (Eaton, Kessler, Wittchen, & Magee, 1994), with two 
clusters, the first being in the range of 15-24 years and the latter, more representative of 
women, being in the 45-54 year range. In certain studies however a different pattern is 
found, with a mean age of onset of approximately 34 years, with no substantial gender 
differences concerning age of onset (Yonkers, Bruce, Dyck, & Keller, 2003). 
 
PD is known to occur among women more often than among men, this disorder 
probably being more than twice as prevalent among women (Carlbring, et al., 2002; 
Eaton, et al., 1998). The expression of PD differs as well; men having, besides an 
earlier age of onset, a shorter duration of illness. Men are also less afflicted by 
agoraphobia but present significantly more often a history of alcohol and/or substance 
dependence/abuse (Clayton, Stewart, Fayyad, & Clary, 2006). 
 
As discussed earlier, agoraphobia has traditionally been seen as merely an effect of un-
treated PD. In other words, that PD would predict future onset of agoraphobia and not 
vice-versa. However longitudinal findings show that primary agoraphobia also predicts 
future onset of PD (Bienvenu, et al., 2006), agoraphobia being in fact the only DSM 
disorder to do so robustly. Agoraphobia may as well be equally related to depression as 
to PAs. In behavioural treatment research a change in avoidance has been seen to be 
more related to change in negative affect than to change in PAs (Ramnerö & Öst, 
2007). 
 
The course of PD shows that spontaneous remission from PD is more common than in 
other anxiety disorders. This is however only true if there is no comorbid agoraphobia. 
PDA is thus, in contrast with PDWA, alongside social phobia, the most chronic anxiety 
disorder with a majority of patients still suffering from the disorder at least 8 years after 
onset (Yonkers, et al., 2003). 
 
Nocturnal PAs occur in 18% to 45% of PD patients (Craske, et al., 2002). There are 
conflicting views on its association with overall PD severity but according to a recent 
study (Albert, Maina, Bergesio, & Bogetto, 2006) nocturnal PAs does not seem to 
indicate higher severity or elevated comorbidity. 
 
Some research show that personality disorder traits, especially avoidant and dependant 
personality, present from early adulthood, may contribute to an increased risk for the 
development of PD and agoraphobia later in life (Bienvenu, et al., 2009; Johnson, 
Cohen, Kasen, & Brook, 2006). They may also increase clinical severity of comorbid 
PD (Ozkan & Altindag, 2005). Other risk factors may include childhood sexual abuse 
(Katerndahl, Burge, & Kellogg, 2005). 
 
PA and PD have also been shown to be associated with coronary heart disease and 
acute myocardial infarction, at least in younger patients (Walters, Rait, Petersen, 
Williams, & Nazareth, 2008). Whether this reflects that PA/PD causes physiological 
changes that elevates the risk of heart disease, or if it simply reflects initial 
misdiagnosis of coronary heart disease and acute myocardial infarction by general 
practitioners, is however not clear. 
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1.2.5.2 Depression 
The median age of onset for a MDE is in the range of 20 to 25 years (Andrade, et al., 
2003) whereas its mean duration has been found to be 16 weeks (Kessler, et al., 2003). 
Research shows that MDEs have a high recurrence rate, and that chronicity often 
develops over time. Solomon and co-workers (2000) found that after the initial episode, 
2/3 of those afflicted experienced at least one recurrence of MDE, and the risk of future 
relapse then progressed so that the risk of recurrence increased by 16% with each new 
MDE. Moreover, the median time to relapse decreased over time with multiple 
episodes; the median time for the first prospectively observed recurrence was 150 
weeks, for the second recurrence it was 83 weeks, and then it continued to shorten with 
new episodes. However, as the duration of recovery increased, the risk of recurrence 
decreased. 
 
Depression can thus be called a “waxing and waning” phenomenon which is dominated 
by relapse, and often, by prolonged chronicity where symptom severity changes over 
time in the same patient and where 1/4 of patients after a MDE still will have chronic 
residual symptoms with merely incomplete remission over several years (Judd, et al., 
1998). In other words, depression is a condition both intermittent and chronic. Persons 
afflicted by it typically have recurrent episodes that persist, but for less than 12-months 
(Andrade, et al., 2003). 
 
Chronic depression has been associated with lower age of onset, elevated suicidality, 
comorbid PD and substance abuse as well as higher rates of familial aggregation 
(Mondimore, et al., 2006). There is both cross-sectional and longitudinal evidence that 
stressful life experiences predict onset of MDEs (Pine, Cohen, Johnson, & Brook, 
2002). It is hypothesized that this is due to stress affecting brain plasticity (Duman, 
Malberg, & Thome, 1999). Among those with MDD, 49% suffer from a mild or 
moderate form of the disorder whereas 39% have severe symptoms and 13% very 
severe (Kessler, et al., 2003). 
 
In the depressive phenotype, certain characteristics may be particularly important for 
understanding the differential severity among those afflicted. One such characteristic is 
the depressive trait of irritability, present in DSM-IV MDD-diagnosis among children 
and adolescents but not in the adult diagnosis. Irritability has been shown to be 
specifically associated to early age of onset, chronicity, comorbidity with anxiety and 
impulse-control disorders, fatigue and self-reproach during episodes, as well as higher 
disability (Fava, et al., 2009). 
 
As it is often a chronic condition, one would expect depression to be highly prevalent 
in old age. However, even if old age poses an elevated risk for depression resulting 
from vascular changes or other age-related physical disorders, it is known that MD 
actually decline towards old age (Jorm, 2000), which could be explained by the 
increase of other psychological protective factors that develop with age (Blazer, 2005). 
On the other hand, there is evidence that depressive symptoms could be a risk factor for 
decline in physical performance and disability in activities of daily living (ADL), even 
at subclinical levels (Hybels, Pieper, & Blazer, 2009). 
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1.2.6 Heredity 
1.2.6.1 Panic disorder 
There is strong support in the research literature for familial aggregation of PD, with 
risk estimates for PD in first-degree relatives of PD probands ranging from 7.9 to 
17.3% compared to 0.7-4.2% in first-degree relatives of controls (Shih, Belmonte, & 
Zandi, 2004). This risk of familial heredity seems particularly prominent among female 
first-degree relatives (Maier, Lichtermann, Minges, Oehrlein, & Franke, 1993). 
Heredity in general seems however specific to PD, whereas the familial liability of 
agoraphobia is less clear (Nocon, et al., 2008). 
 
There is also specific support for a genetic contribution to the development of PD, and 
a meta-analysis of twin studies describes a genetic contribution of 43% (Hettema, 
Neale, & Kendler, 2001). Studies overall show a 2-3 times higher concordance rate 
among dizygotic then among monozygotic twins (Shih, et al., 2004).  
 
What genes do then account for these genetic differences? Because of the known effect 
of serotonergic drugs for PD, the influence of the serotonin system and more 
specifically the serotonin transporter protein (5-HTT) has become a major focus of 
research on candidate genes (Bell & Nutt, 1998; Lesch, et al., 1996). One such gene is 
the 5-HTT-linked polymorphic region (5-HTTLPR) located on chromosome 17. It is a 
functional 43BP insertion/deletion polymorphism2 yielding a short (s) or long allele 
(l)3. The s-allele has been shown to be associated with amygdale reactivity (neural 
correlate of fear response) (Munafo, Brown, & Hariri, 2008) and neuroticism (Munafo, 
et al., 2009). Moreover, it has recently been shown that it is more specifically involved 
in fear learning by amplifying the startle response (Lonsdorf, Weike, et al., 2009). 
However, its association to the diagnostic entity of PD is not conclusive (Blaya, Salum, 
Lima, Leistner-Segal, & Manfro, 2007).  
 
In a study by our group (Lonsdorf, Rück, et al., 2009) patients from Study IV were 
asked to participate in an additional study, by giving permission to genetic analysis of 
blood samples. The methods used in the study are detailed elsewhere (Lonsdorf, Rück, 
et al., 2009). We investigated the association of 5-HTTLPR and symptom severity 
among PD patients using the Panic Disorder Severity Scale (PDSS) scores (see Study 
IV). Besides the biallelic analysis (of s and l alleles), a triallelic analysis was also 
performed including a SNP (AG) located in conjunction with the 5-HTTLPR. The 
G-allele of this SNP has been shown (as has the s allele in 5-HTTLPR) to reduce 
serotonin (5-HT) expression in the brain (Kraft, Slager, McGrath, & Hamilton, 2005). 
One previous (case-control) study has analysed the association between triallelic 5-
HTTLPR and PD, showing no relation (Strug, et al., 2010).  
                                                
2 A base pair (BP) consists of two nucleotides (the molecules structuring DNA) connected by a hydrogen 
bond, on opposite sides of the DNA strand. Several BPs form a DNA sequence. Polymorphism denotes a 
variation in a single BP (single nucleotide polymorphism, SNP), or in a sequence of BPs, that is common 
in the population. 
3 An allele denotes one variant of a polymorphism at particular place along the DNA strand. In this case, 
“43BP insertion/deletion” means that the short allele lacks 43BP that the long allele has. 
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The results of our study showed that patients with the 5-HTTLPR s-allele did have a 
significant higher panic severity (as measured by the PDSS), thus showing an 
association between 5-HTTLPR and panic, in contrast with much earlier research. This 
stresses the importance of a more fine-tuned definition of the phenotype of interest. 
Much psychiatric genetic research has probably too heavily relied on case-control 
studies and the quite crude entities of DSM-IV diagnoses. Continuous ratings such as 
the PDSS is simply better than dichotomous diagnostics in reflecting the phenotypic 
variance of PD, an issue which has been previously discussed in the literature (Smoller 
& Tsuang, 1998). In our study we analyzed not diagnosis but symptomatic profile and 
could thus find an association that would have been lost in the traditional case-control 
design. Our data thus highlight the importance of defining appropriate phenotypes for 
psychiatric genetic studies. 
 
In a second study by our group (Lonsdorf, et al., 2010), again using blood samples 
from patients in Study IV, we examined the role of the functional polymorhpism 
COMTval158met4 for understanding response pattern in our CBT treatment. The met-
allele has previously been shown to be associated with, among other things, resistance 
to fear extinction in experimental settings (Lonsdorf, Weike, et al., 2009) and was 
therefore examined in this trial, whose methods are detailed elsewhere (Lonsdorf, et al., 
2010). The most significant result of this study was that patients with the met/met 
genotype showed significantly less symptom relief during the exposure modules of the 
treatment (modules 6 to 9, see Study IV for details) as compared to COMT 158val-
carriers. We thus found tentative evidence that PD patients with the met/met genotype 
(compared to those with at least one val-allele) may not respond as well to exposure in-
vivo as part of a CBT treatment. This is significant, in the sense that it reflects earlier 
experimental findings of the effect of the COMTval158met polymorphism on 
extinction of fear, which is posited to be the mechanism of action behind the 
therapeutic effects of exposure. 
 
Future research in the direction that these two studies have marked out may hopefully 
allow a finer understanding of the genetic contributions to the development and clinical 
manifestation of PD as well as to a better understanding of treatment response patterns 
in pharmacological as well as in psychological treatment. 
1.2.6.2 Depression 
MDD is considered to be a heterogeneous and moderately heritable disorder, with the 
greatest familial risk among those with recurrence of MDEs, worse impairment, and 
early age of onset (Levinson, 2006; Milne, et al., 2009), although the latter is less 
conclusive. Relatives of probands with bipolar disorder (BD) show higher risk of 
developing MDD, whereas the reverse is not the case (McGuffin, et al., 2003). 
 
                                                
4 val158met is a functional single nucleotide polymorphism (SNP) of the gene for catechol-O-methyl 
transferase (COMT) that has been shown to be related to many functions, among them cognitive tasks 
and fear extinction. 
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Studies on the genetic contribution to MDD comparing concordance rates between 
monozygotic and dizygotic twins reveal a heritability of about 37% (Sullivan, Neale, & 
Kendler, 2000). This heritability is higher in women (42%) than in men (29%) 
(Kendler, Gatz, Gardner, & Pedersen, 2006). It has also been shown in a twin study that 
at least among women, genes modify the susceptibility to stressful life experiences and 
therefore influences onset of MDD (Kendler, et al., 1995). 
 
The question is then which candidate genes that could account for these findings. In 
this line of research the 5-HTTLPR (Lesch, et al., 1996) mentioned earlier has also 
been associated with neural correlates connected to depressive symptoms (Pezawas, et 
al., 2005). Evidence for its direct relation to MDD is however inconclusive (Lesch, 
2003), but research has revealed that if not directly related to depression, it could well 
be indirectly related by moderating the serotonergic response to stressful life events 
(Levinson, 2006). 
 
In a much-cited prospective epidemiologic study, Caspi and co-workers (2003) found 
that the 5-HTTLPR predicted onset of depression, but only in association with stressful 
life experiences. More specifically, carriers of the s allele showed more depressive 
symptoms, MDD diagnosis, and suicidality in relation to stressful life experiences than 
carriers of two l alleles (homozygous). It was suggested that this observed interaction 
between genes and environment could be explained epigenetically, that is, that 
environmental factors produce a predisposition to depression by altering gene 
expression. However, even if this study has been partly replicated, a recent meta-
analysis (Risch, et al., 2009) has called into question this “serotonin gene-life stress 
hypothesis”. The meta-analysis concludes that 5-HTTLPR does not improve the 
prediction of risk of MDD beyond that associated with exposure to stressful life 
experiences, the latter being a known risk factor for MDD-onset (Pine, et al., 2002). 
  
Genetic research on broadly defined diagnostic entities such as PD, and to an even 
higher degree MDD, has increasingly been called into question, because of the large 
genetic heterogeneity associated with these disorders. As discussed above concerning 
PD and the studies by our group (Lonsdorf, Rück, et al., 2009; Lonsdorf, et al., 2010), 
future research lies probably in defining less broad phenotypes such as symptomatic 
profiles (not necessarily related to diagnosis), as these may identify cases that share 
genotype. 
1.2.7 Pharmacological treatment 
There are a number of groups of pharmacological agents, most of them used for both 
PD and MDD, who have shown to be effective in treating these disorders. They are the 
selective serotonin reuptake inhibitors (SSRI) and serotonin/noradrenaline reuptake 
inhibitors (SNRI), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors 
(MAOIs) and the anxiolytics (benzodiazepines).  
 
SSRI/SNRIs, often called the “new generation antidepressants” have been introduced 
for the treatment of PD and MDD the past 20 years. They affect the reuptake of 
serotonin and/or noradrenalin in the synaptic cleft by altering the function of the 
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proteins SERT (serotonin transporter) and NAT (noradrenalin transporter) (Artigas, 
Nutt, & Shelton, 2002). Examples of such drugs are citalopram, escitalopram, 
duloxetine, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine.   
 
TCAs are a group of early antidepressant drugs, introduced in the 1950s. Most TCAs 
function by altering the function of SERT and NAT, as do the SNRIs (Stahl, 1998). 
Examples of these drugs are amitriptyline, nortriptyline, clomipramine and imipramine. 
 
MAOIs are another older group of drugs that have in common that they inhibit the 
activity of the enzyme MAO, and thus effect transmission of monoamine 
neurotransmitters such as serotonin, noradrenaline and dopamine. Different MAOIs are 
more selective than others as to which neurotransmitters they affect (Stahl, 1998). 
There are two different forms, the early irreversible MAOIs and the more recent 
reversible MAOIs. Examples are phenelzine, moclobemide and selegiline. 
 
Among anxiolytics the most common group of drugs are the benzodiazepines (BZDs). 
The shared mechanism of action of these structurally related drugs is their effect on the 
neurotransmitter gamma-aminobutyric acid (GABA), the primary inhibitory 
neurotransmitter in the central nervous system (CNS) (Campo-Soria, Chang, & Weiss, 
2006). These drugs are categorized following their short-, intermediate- or long-acting 
effect, which depend upon their half-life properties. Examples are alprazolam, 
clonazepam, diazepam, flunitrazepam, and oxazepam. 
1.2.7.1 Panic disorder 
SSRI/SNRIs constitutes the pharmacological treatment of choice for PD (American 
Psychiatric Association, 1998), and are considered rather homogenous in their efficacy 
profile, whereas differences rather can be found when it comes to issues of safety and 
side effects. Common side effects are gastrointestinal symptoms, agitation, sleep 
disturbance, weight gain and impaired sexual function and/or desire, however 
considered less prominent than among earlier pharmacological treatments (Dannon, et 
al., 2007). Paroxetine distinguishes itself from the other SSRIs because of its additional 
effect on the noradrenergic and cholinergic system, hypothesized to account for a mild 
sedating effect and thus to be of possibly additional value in the treatment of PD. If 
there is no robust support for strong differential gender effects from SSRIs, there is 
some evidence that women possibly could benefit more from certain SSRIs at least 
when it comes to reduce panic frequency (Clayton, et al., 2006). 
 
Since the 1960 the effects of TCAs on PD has been known (Klein, 1964) through 
several reports in support for their efficacy (Barlow, Gorman, Shear, & Woods, 2000; 
Mavissakalian & Perel, 1995) but there are concerns surrounding their use. Among 
those concerns one finds numerous side effects including tremors, weight gain, and 
sexual dysfunction (Roy-Byrne & Cowley, 2002) as well as possible hypertension 
(Louie, Louie, & Lannon, 1992). Since the introduction of the SSRIs the role of TCAs 
has thus become less clinically important. Even if showing similar efficacy, SSRIs are 
better tolerated than TCAs (Bakker, van Balkom, & Spinhoven, 2002)  
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The MAOIs have been shown to be effective in PD treatment as well (Riederer, 
Lachenmayer, & Laux, 2004; Sheehan, 1984). However, being a group of drugs that 
effect broad neuronal systems in the body, especially the first generation of MAOI 
drugs are known to have substantial side effects. Particularly first-generation MAOIs 
are also accompanied by dietary restrictions (Sweet, et al., 1995). 
 
BZDs are still the most commonly prescribed pharmacological treatment for PD 
(Bruce, et al., 2003), and have been shown to be effective in reducing PD symptoms 
(Ballenger, et al., 1988; Schweizer, et al., 1990). However, discontinuation and soon 
relapse are also known problems (Chouinard, 2004). A large issue surrounding BZDs is 
the one of dependence (Ashton, 2005). While it is clear that many patients demonstrate 
addiction to BZDs, many researchers judge that it is inconclusive whether this reflects 
an underpinning (physical) dependence or is best construed as a psychological 
addiction (de las Cuevas, Sanz, & de la Fuente, 2003). 
1.2.7.2 Depression 
Somewhat over half of those (57.3%) suffering from MDD receive some form of 
treatment (Kessler, et al., 2003), primarily SSRIs. As in PD, SSRIs are considered the 
pharmacological treatment of choice for MDD (American Psychiatric Association, 
2000b).  
 
SSRI/SNRI medication is often considered to have similar efficacy and acceptability 
profiles when it comes to treating MDD (see treatment for PD, above). However, in a 
recent large meta-analysis (Cipriani, et al., 2009) including 117 studies and 25 928 
individuals randomly assigned to 12 different antidepressants, sertraline was considered 
the best medication when drawing together considerations on efficacy, acceptability, 
and acquisition cost.  
 
SSRIs and TCAs are considered to be equally effective in treating MDD, but 
SSRI/SNRIs seem to be better tolerated with less side effects (MacGillivray, et al., 
2003). A higher risk for development of coronary heard disease (CHD) is a serious 
possible side effect of TCAs that has been evoked (Rosenberg, et al., 2010). A major 
issue in SSRI and TCA treatment is that of relapse prevention, where data suggest that 
continued treatment can reduce risk of relapse by 70% (Geddes, et al., 2003). However, 
data suggest that in reality, maintenance of pharmacotherapy for MDD may be 
relatively poor (Holma, Holma, Melartin, & Isometsa, 2008). 
 
The MAOIs have most often been used in the treatment of so called atypical 
depression, and have been shown to be selectively more efficacious than other 
antidepressants for this subgroup of depressive symptoms (Thase, 2007). These 
symptoms distinguish themselves from classical depressive symptoms such as 
psychomotor inhibition, loss of sleep (insomnia) and appetite, energy and interest. 
Atypical symptoms are instead characterised by heightened emotional reactivity and 
interpersonal sensitivity, increased sleep (hypersomnia), increased appetite and weight 
gain, and fatigue (Thase, 2007). 
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Anxiolytics (benzodiazepines) are primarily used as adjuncts to antidepressant 
treatment for MDD, and there is support for their efficacy in the treatment of patients 
with prominent comorbid anxiety symptoms, a treatment rational commonly used in 
clinical settings (Dunlop & Davis, 2008). 
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1.3 PSYCHOLOGICAL TREATMENT OF PANIC 
DISORDER AND DEPRESSION 
1.3.1 Brief background to CBT 
Behaviour therapy (BT) has its theoretical roots in the experimental psychology of 
learning and in what is known as the radical behaviourism of B.F. Skinner (1988). It is 
built upon the principles of respondent (“classical”) and operant conditioning (Skinner, 
1965). This tradition applies the methods of natural science to the study of human 
behaviour, but originally by way of experimentally studying animal behaviour 
(Skinner, 1975). The principle of respondent conditioning, first described by the 
physiologist Ivan Pavlov (1927), means that previously neutral stimuli can acquire the 
functions of stimuli with which they were paired closely in time (Lavond & Steinmetz, 
2003). The principle of operant conditioning means that behaviour is (also) governed 
by its consequences, by way of being either reinforced (increase in future behaviour) or 
punished (decrease in future behaviour). Behaviour can both be positively reinforced 
(the consequence being the presentation of an appetitive stimulus) or negatively 
reinforced (the consequence being the removal of a pre-existing aversive stimulus, or 
the non-appearance of an expected aversive stimulus). The concept of punishment, for 
clinical implications less important than that of reinforcement, can also be divided into 
positive punishment (the consequence of the behaviour being the presentation of an 
aversive stimulus) and negative punishment (or “response cost”, the consequence of the 
behaviour being the removal of an appetitive stimulus). Taking these principles 
together and applying them to the behaviour of a specific individual is called functional 
analysis (Ramnerö & Törneke, 2008), which is the basic analytical tool used in what is 
called applied behaviour analysis (ABA) (Austin & Carr, 2000) and in what was to 
become BT (Eysenck, 1960). Two basic assumptions in BT are: (1) the clinical 
approach can use the experimental methodology otherwise used in research 
(measuring, hypothesizing, testing, etc), and (2) dysfunctional behaviours (as in 
phobias, panic and depression) are acquired in the same manner as other, “normal” 
behaviours. As a consequence, new learning experiences (acquired for instance during 
therapy) can come to change the old ones. 
Former psychoanalyst Aaron T. Beck is considered to be the “father” of 
cognitive therapy (CT), which he developed originally in the psychotherapy of patients 
with depression (Beck, Rush, Shaw, & Emery, 1979), but is now a form of 
psychotherapy for many different psychiatric disorders. The theory underpinning CT 
holds that cognitions are the fundamental causal agents behind emotion and behaviour, 
often named negative automatic thoughts (NATs) (Beck, 1995). NATs arise when 
something in the environment activates dysfunctional “schemas“ (mental structures 
posited to have evolved during earlier life experiences). A fundamental CT technique is 
to make NATs apparent, by way of for instance thought records, and then to dispute 
these thoughts, by way of cognitive restructuring techniques (Beck, 1995). 
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Cognitive behaviour therapy (CBT) can be said to be an amalgam of CT and BT, where 
therapeutic techniques stemming from both cognitive and behaviour therapy are used. 
Behavioural techniques such as behavioural activation (BA) and exposure in-vivo were 
from the very start integrative parts of CT, although given other names and integrated 
into a cognitive rational for their therapeutic use (see below).  
 
A more specific description of psychotherapy models and techniques as well as their 
empirical support will now be given below. 
1.3.2 Panic disorder  
The earliest reports of the efficacy of behavioural treatments for agoraphobia and panic, 
based on respondent- and operant principles, emerged in the 1960s, however focusing 
more on agoraphobic avoidance than on panic symptoms per se (Agras, Leitenberg, & 
Barlow, 1968; Gelder & Marks, 1966). These as well as subsequent behavioural 
treatments focus on the patient’s avoidance of both internal and external anxiety cues. 
In other words, panic- and agoraphobic symptoms are construed as resulting from both 
respondent and operant behavioural processes. First, by way of classical conditioning, a 
previously neutral stimulus (like a crowded public space or the bodily sensation of 
slightly elevated heartbeat) becomes a conditioned stimulus eliciting a fear response. If 
the individual would reengage the same situation several times, without escaping, the 
fear response would be extinguished. However, what maintains the fear response in the 
long run are the negatively reinforced escape and avoidance behaviours engaged in by 
the individual preventing extinction of the fear (Barlow, 2002). From this behavioural 
account follows that treatment should incorporate exposure to the feared stimuli and 
prevent escape and avoidance, after which the fear response will extinguish. In PD, this 
can involve both in-vivo- and interoceptive exposure, that is, exposure to both external 
stimuli (like crowded public spaces) and internal stimuli (like elevated heartbeat). 
 
Up until the 1980s David H. Barlow and co-workers continued their research initiated 
in the 1960s, increasingly focusing also on PAs (Barlow, et al., 1984), resulting in a 
CBT-treatment package called Panic Control Treatment (PCT). At this point it had also 
come to include cognitive interventions (Barlow & Craske, 2000). 
 
The interest in cognitive therapy and theory increased markedly in the 1980s. In a 
seminal article, David M. Clark proposed a cognitive conceptualisation of PA and PD 
(Clark, 1986), pursuing the work on anxiety by Aaron T. Beck (Beck, Emery, & 
Greenberg, 1985). This model proposed that a PA arises from patient misinterpretations 
(cognitions) of bodily sensations (as for instance slightly elevated heart rate) as a sign 
of danger (“Maybe I’m having a heart attack!”) which in turn will elevate the 
sympathetic nervous response even further, entailing a vicious circle of anxiety 
symptoms and catastrophic cognitions, eventually culminating in a panic attack. To 
break this vicious circle, cognitive therapy involves the making apparent of these 
NATs, and then to engage in cognitive restructuring, that is, to modify the fear-
inducing content of the thoughts and developing a more realistic cognitive appraisal of 
the physiological symptoms. The cognitive account also includes a focus on avoidance 
behaviours, but they are interpreted differently in the cognitive model than within the 
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behavioural approach (where they are seen as negatively reinforced avoidance 
behaviours preventing extinction of the fear response). In cognitive therapy the goal is 
still behaviour change (i.e. encouraging the patient to cease doing avoidance 
behaviours), but the proposed mechanism of action is construed as that by doing so 
fear-related cognitions are altered, and the previous causes of PAs are therefore 
dismantled (Beck, et al., 1985; Beck, et al., 1979). 
 
An other treatment within the behavioural tradition is applied relaxation (AR) (Öst, 
1987), which teaches the patient to recognize early cues of anxiety, and to then to cope 
with the anxiety in these situations by engaging in a relaxation technique, first learned 
in non-threatening situations. There is evidence that AR is equally effective as exposure 
treatment as well as CBT in the treatment of PDA (Öst, Westling, & Hellström, 1993) 
and that it is equally effective as CBT in the treatment for PDWA (Öst & Westling, 
1995), with symptom reductions sustained at 12-month follow-up. 
 
There is extensive evidence for the efficacy of CBT for PD (with or without 
agoraphobia) in reducing panic and related symptoms, both in acute phase and in 
follow-up (Clum & Surls, 1993; Mitte, 2005; van Balkom, et al., 1997; Westen & 
Morrison, 2001) as well as evidence for the specificity of CBT effect on PD (Siev & 
Chambless, 2007). CBT is thus the most clearly empirically supported treatment (EST) 
(Chambless & Hollon, 1998) for PD. CBT and BT seems to render similar results in 
treatment of PDA (Öst, Thulin, & Ramnerö, 2004), whereas there is some evidence that 
CBT reduces attrition and is more effective in reducing comorbid depressive 
symptoms. The best evidence for the treatment of agoraphobic symptoms seems to be 
in-vivo exposure, but agoraphobic severity is a negative predictor of treatment outcome 
(Ramnerö & Öst, 2004). There is evidence that combining pharmacological treatments 
and CBT/BT is more effective than either treatment alone in the acute treatment phase 
of PD (with or without agoraphobia) but that there may be an advantage for CBT/BT 
when long-term effect, discontinuation and side-effects are taken into account 
(Furukawa, Watanabe, & Churchill, 2006) 
 
A specific model for the psychodynamic understanding of PD has been developed, 
called panic-focused psychodynamic psychotherapy (PFPP). It states that unconscious 
fantasies can underlie panic symptoms, and that a PA can be understood as the result of 
intrapsychic conflict. This psychodynamic treatment has been evaluated in one RCT 
(Milrod, et al., 2007). In this trial 49 patients were randomised to either PFPP or a 
treatment that was called applied relaxation (AR). The results showed that PFPP 
patients had a significantly greater reduction in panic symptoms than those in the 
comparison condition, as well as a higher response rate. However, it is less than clear if 
the AR treatment actually was in accordance with the behavioural coping technique 
developed by Öst (1987).  
1.3.3 Depression 
As with anxiety the first accounts of a theoretical understanding of depression within 
the CBT tradition stems from operant principles. Charles B. Ferster, one of Skinners 
students and collaborators, published in 1973 a seminal work on the functional analysis 
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of depression (Ferster, 1973) where he stipulated that depression can be explained by a 
reduction in positively reinforced behaviours and in an increase in negatively 
reinforced escape- and avoidance behaviours, including also verbal behaviours like 
complaining. From this account follows that effective treatment should focus on 
monitoring daily activities and mood, and aim to increase positively reinforced 
behaviour (often called “pleasurable activities”) (Lewinsohn, Munoz, Youngren, & 
Zeiss, 1986). 
 
While behavioural interest in the treatment of depression grew during the 1970, much 
following the work of Peter M. Lewinsohn (1974), relatively soon research and clinical 
work became dominated by Becks CT (Beck, et al., 1979). CT stipulates that low mood 
and other depressive symptoms are caused by NATs and that the therapeutic goal is, as 
in CT for PD, to dispute these thoughts using different cognitive restructuring 
techniques. Just as in CT for PD however, the CT model for depression has always 
included behavioural techniques, but administered with a cognitive treatment rational. 
 
In 1996 Neil Jacobson and co-workers (1996) published a component analysis of CT 
for depression showing that the specific cognitive therapeutic techniques were not 
necessary to obtain treatment effect; that is, that the behavioural techniques on their 
own were just as effective as the whole CT treatment package. Subsequent trials have 
confirmed these results, also in long-term follow-up and in comparison to 
pharmacotherapy (Cuijpers, van Straten, & Warmerdam, 2007; Dimidjian, et al., 2006; 
Dobson, et al., 2008; Gortner, Gollan, Dobson, & Jacobson, 1998). This called into 
question the cognitive model of depression and gave birth to a renewed interest in 
behaviour therapy for depression, in the form of a specific behavioural treatment model 
called behavioural activation (BA) (Hopko, Lejuez, Ruggiero, & Eifert, 2003; Martell, 
Addis, & Jacobson, 2001) 
 
Several meta-analyses demonstrate that CT/CBT is an effective treatment intervention 
for depression both after the acute treatment phase and at follow-up, with moderate to 
large effect sizes (ES), but with possibly only partial success in preventing relapse 
(Dobson, 1989; Gloaguen, Cottraux, Cucherat, & Blackburn, 1998; Reinecke, Ryan, & 
DuBois, 1998; Vittengl, Clark, Dunn, & Jarrett, 2007). BA alone has also shown to be 
an effective treatment, demonstrating a large ES (Cuijpers, et al., 2007) that is 
comparable to studies of CBT (Mazzucchelli, Kane, & Rees, 2009). 
 
Another treatment evaluated in treatment of depression is brief psychodynamic therapy 
or short-term psychodynamic psychotherapy (STPP). The theoretical base of this 
treatment is psychoanalytic theory and focuses on certain intrapsychic conflicts, but 
being more time-limited and “here and now”-oriented and with a more active therapist 
than in traditional psychodynamic therapy (PDT) (Messer & Warren, 1995). There is 
evidence that STPP is effective in reducing mild to moderate depressive symptoms, and 
that it is equally effective as CBT in this regard (Cuijpers, et al., 2008; Leichsenring, 
2001). 
 
Interpersonal therapy (IPT) is often, but not always, considered to be a form of brief 
PDT (Leichsenring, Rabung, & Leibing, 2004; Markowitz, Svartberg, & Swartz, 1998). 
However, whereas STPP is largely a generic therapy, less structured and focused on 
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intrapsychic conflict, IPT is a depression specific, structured and more pragmatic 
therapy focusing on the patients interpersonal problems (Markowitz, et al., 1998).  
 
In comparison to antidepressant medication, the large, field-based and much-cited 
NIMH Treatment of Depression study (Elkin, et al., 1989) showed that CT was as 
effective as interpersonal therapy but that both psychological treatments were less 
effective than the TCA imipramine. There is however later evidence that CT/BA is as 
effective as anti-depressant medication, even in severely depressed out-patients 
(DeRubeis, Gelfand, Tang, & Simons, 1999; DeRubeis, et al., 2005; Dimidjian, et al., 
2006) and also in preventing relapse after discontinuation (Dobson, et al., 2008; 
Hollon, et al., 2005). There is some evidence that the combination of anti-depressant 
medication and psychological treatments renders superior treatment effects than 
psychological treatment alone in acute treatment phase (Cuijpers, van Straten, 
Warmerdam, & Andersson, 2009), however this may not be the case at follow-up, or 
when CBT specifically is combined with pharmacotherapy. 
 
Comparing IPT, PDT and CBT in a meta-analysis, Cuijpers and co-workers (2008) 
found no significant differences in treatment effect, besides that IPT could possibly be 
more efficacious than the other treatments for mild to moderate depression.  In a recent 
subsequent meta-analysis Cuijpers et al. (2009) holds however that effects of 
psychological treatments for depression in fact have been generally over-estimated, by 
not taking into account the quality of studies analysed. 
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1.4 MAKING PSYCHOLOGICAL TREATMENT 
ACCESSIBLE 
As discussed above, both depression and PD are common psychiatric conditions which 
cause a heavy disease burden, and for which we know of effective treatments, both 
psychological and pharmacological. However, whereas access to pharmacological 
treatments may be said to be satisfactory, access to the empirically supported 
psychological treatments is still a great concern that public policy makers increasingly 
have started to call attention to (Clark, et al., 2009). That is, the research literature 
clearly shows that there are numerous efficacious psychological treatments for 
depression and PD, but these treatments do not, to a sufficient degree, reach patients in 
the health care system, largely due to the lack of therapists trained in these treatments. 
How can this state of affairs be changed? One solution has been to increase the 
patient’s own involvement in therapy and decreasing the presence of the therapist, 
notably by different forms of psychological self-help approaches and by briefer 
therapist contact (den Boer, et al., 2004; Richards, Lovell, et al., 2003).  
1.4.1 Self-help and bibliotherapy 
The term “bibliotherapy”, although earlier broadly defined as all written materials, 
including literary fiction, used to alleviate physical or psychological problems (Alston, 
1962), has increasingly been used to denote the use of specific self-help books in the 
treatment of psychiatric problems. By the mid 1970s researchers within the behavioural 
tradition had started to evaluate the effects of behavioural bibliotherapy (Goldiamond, 
1976; Rosen, Glasgow, & Barrera, 1976). That this evolved within behaviour therapy is 
understandable given its focus on learning principles and the proposed mechanism of 
action which is concrete behaviour change. As manuals have always been used within 
this tradition, it has since the beginning, for the sense of clarity, been important to make 
the distinction between, on the one hand, “pure self-help”, called self-administered 
treatments, and on the other hand, therapist-administered treatments (Glasgow & 
Rosen, 1978). Between these two one finds the term “minimal-contact therapy” or 
“guided self-help”, namely when the treatment fundamentally relies on the patient’s 
own appropriation of the treatment manual, but where a therapist gives support, by for 
instance brief telephone or e-mail contact. Therapist-administered treatment (using a 
treatment manual) is in turn contrasted with therapist directed treatment, where a 
manual is not used and the whole treatment relies on contact with the therapist 
(Glasgow & Rosen, 1978). Internet-based treatment, discussed in detail below, should 
be seen as an example of guided self-help in this regard.  
 
There is a relatively large evidence base for the efficacy of self-help approaches, with 
various degrees of therapist involvement, both for depressive symptoms (Anderson, et 
al., 2005; Cuijpers, 1997; McKendree-Smith, Floyd, & Scogin, 2003) and PD 
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(Carlbring, Westling, & Andersson, 2000; Gould, Clum, & Shapiro, 1993). This 
evidence will be reviewed below. 
1.4.1.1 Treatment outcome 
A meta-analysis on bibliotherapy for depression by Pim Cuijpers (1997) included 6 
studies that evaluated CBT programmes with either predominantly cognitive (Burns, 
1999) or behavioural (Lewinsohn, et al., 1986) content. All studies in this meta-analysis 
included therapist contact, which in most cases was on a weekly basis. It reflects thus 
what has been called guided self-help. The comparisons of bibliotherapy and waiting-
list yielded a large average between-group effect size of Cohen’s d=0.82. Analysing the 
comparisons of guided bibliotherapy and individual therapy, the effect size was d=0.10, 
indicating no important differences in efficacy. In a subsequent meta-analysis of 20 
studies evaluating a specific bibliotherapy, namely Peter Lewinsohns “Coping with 
depression course” (CWD) (1984), Cuijpers (1998) showed that compared to control 
conditions, CWD (including therapist/”teacher” contact) rendered a mean between-
group effect size of d=0.65, while the within-group effect size was d=1.21. 
 
In a later meta-analysis on CBT-based bibliotherapy for depression, less 
methodologically stringent, Gregory and co-workers (2004) included more studies than 
the previous analysis by Cuijpers. A total number of 29 studies were found, with an 
average between-group (comparison with control condition) effect size of Cohen’s 
d=0.77 and an average within-group effect size of d=1.20. A separate analysis was 
made between group-administered and “self-administered” (though still with 
guidance), yielding no difference in effect (d=0.99 and d=0.98 respectively). 
 
In yet another, more recent, meta-analysis on self-help studies for depression including 
34 studies, Gellatly and co-workers (2007) showed that studies with higher efficacy 
were those that to a higher degree used observer-rated outcome measures, recruited 
participants from non-clinical settings but with a diagnosis of depression (and not 
purely prevention of depressive symptoms), and who included contact with a therapist 
(guided self-help). However, of these factors, only guidance showed to be statistically 
significant in the multivariate analysis. 
 
In a meta-analysis on bibliotherapy by Gould and Clum (1993), including 40 studies of 
a wide range of different target problems, an average between-group effect size of 
Cohen’s d=0.76 was found at post-treatment, and d=0.53 at follow-up. The average 
effect-size for the 8 studies evaluating interventions of “fear reduction” (5 of them 
explicitly targeting “phobia or panic disorder”) was 1.11. Moreover, in a comparison of 
“pure” self-help versus self-help with minimal therapist contact, no significant 
differences were found. It is however difficult to judge this finding, since information 
was somewhat scarce on the exact nature and amount of contact with a professional 
that still was a part of the “pure” self-help studies (as “assessment”). 
 
Another meta-analysis published by den Boer and co-workers (2004) including 14 
studies of mood- (9 studies) and anxiety disorders (4 studies; with one study of mixed 
anxiety/depression) showed an average between-group effect size (comparisons with 
control/wait-list) of d=0.84 at post-treatment and d=0.76 at follow-up. 
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Summing up, there is a relatively solid evidence base for bibliotherapy for depression 
as well as for PD, at least when it is guided by a therapist. However, the exact 
contribution of therapist guidance specifically versus treatment structure more 
generally (careful in-person assessment before and after treatment etc) is not well 
elucidated. In a recent trial on PD it was shown that even unsupported bibliotherapy 
was effective, when accompanied by a clear deadline of treatment completion (Nordin, 
Carlbring, Cuijpers, & Andersson, 2010) 
1.4.2 Internet-based treatment 
Thus, we know of efficacious psychological treatments for depression and PD, but 
these treatments have a relatively low degree of access. We also know that self-help 
approaches may be one solution to the problem of dissemination and accessibility.  
 
However, despite that there is evidence for the efficacy of guided self-help approaches 
since at least 30 years back, they have to a large degree been neglected within health 
care (den Boer, et al., 2004). Thus, as indicated earlier, they have not managed to 
significantly improve access for patients to empirically supported psychological 
treatments. 
 
The advent of computers and the Internet may have come to provide a solution to this 
problem, by providing new, more efficient ways of delivering self-help programmes as 
well as brief therapist contact (Hohl, Berger, Bergström, Andersson, & Caspar, 2010). 
As will be outlined below, Internet treatment provides an integrated structure for the 
combined deliverance of self-help material and therapist contact, that may more easily 
be disseminated within the health care system than printed books, manuals and in-
person therapist guidance (Andersson, 2009).  
1.4.2.1 Computers, Internet and psychotherapy 
The idea of using modern technology in psychotherapy and in the treatment of 
psychiatric problems is not new. An early example of the use of computers in this area 
was ELIZA, a computer programme conceived by Joseph Weizenbaum (1966), that 
could emulate responses in the manner of a non-directive Rogerian psychotherapist. 
This early, partly parodical, example was in other words aimed at substituting the 
therapist, that is, the patient being only in interaction with a programme. 
 
ELIZA actually points to a fundamental difference in the stance taken by different 
researchers in the area of computerised or Internet-based treatment ever since. This 
difference basically reads: the technology developed, is it there to substitute the 
therapist or to complement him or her? Or rephrased in line with the discussion raised 
above: is the developmental goal a self-administered treatment or is it a minimal-
contact/guided-self-help treatment? The impact of these questions will be elucidated 
below. 
 
 26 
Following a rise of interest in the general use of computers in psychiatry in the 1970s 
(Klein, Greist, & Van Cura, 1975), in the early 1980s researchers increasingly started to 
investigate computerised assessment for psychiatric patients with for instance anxiety 
(Carr & Ghosh, 1983). The step to psychological treatment was then not far for 
researchers within the behavioural bibliotherapy tradition. Isaac Marks and co-workers 
developed a treatment of “self-exposure” for agoraphobia not only in book- but also in 
computer form (Ghosh, Marks, & Carr, 1984). In this early example of what was later 
to be called computerised cognitive behaviour therapy (CCBT) (Baer, Greist, & Marks, 
2007) one already finds the idea of therapist substitution where “the computer was 
programmed to 'discuss' exposure tasks” (Ghosh, et al., 1984). However, in the 
subsequent randomised trial that found support for efficacy, all patients actually did see 
a clinician before and after treatment, during which all participants also had minimal 
therapist contact (Ghosh, Marks, & Carr, 1988).  
 
The work by Marks and co-workers engendered the development of several interactive 
applications for stand-alone computers and for CD-ROMs, like “Fear Fighter” 
(Kenwright, Liness, & Marks, 2001) for anxiety and “Beating the Blues” (Proudfoot, et 
al., 2004) for anxiety and depression, both showing efficacy in reducing phobic and 
depressive symptoms respectively. These programmes were also, as their somewhat 
“catchy” names may reveal, commercial products. 
 
However, in the mid 1990s the advent of the Internet changed, among many things, the 
role of computers. If the primary goal of the computer user previously was to interact 
with computer programmes, even so elaborate, since the advent of the Internet the 
primary goal of the user is to interact with the world, that is, largely with other people – 
personally as well as professionally. This also changed the area of computer assisted 
psychological treatment, partly shifting the focus from (self administered) interactive 
computer programmes to Internet based self-help applications with integrated minimal 
therapist contact (Andersson & Carlbring, 2003). 
 
However, many conceptual confusions (and controversies) still surround the area of 
computer- and Internet based CBT. While some follow the example of ELIZA, like 
Marks and co-workers (2007), and holds that the very raison d’être of these 
interventions is largely to delegate the unique function of the therapist to the computer 
or Internet application, others, like our group (Andersson, Bergström, et al., 2008) hold 
that this is not necessary or even desirable. In our perspective, what is important is not 
the technology per se but the over-arching goal of enhancing access to psychological 
treatments, made possible by the significant reduction in therapist time when using 
guided self-help (Andersson, 2009), even when using technologically simple self-help 
applications. That is, the fact that more elaborate interactive computer programmes 
seek to emulate therapist functions, like decision making or therapist feedback, does 
not necessarily enhance neither treatment effect nor cost effectiveness. These 
technologically advanced programmes also often need commercial involvement for 
their development to be possible, raising several additional problems, namely the 
sometimes conflicting interests between commercial and scientific enterprise (Rosen, 
1987). 
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The studies in this thesis are thus trials of Internet-based psychological treatments, and 
the review of previous treatment outcome research below will focus on studies in this 
line of work (rather than on computerised stand-alone programmes). This also reflects 
the development in the field, where evaluations of non-Internet-based computerised 
applications are increasingly scarce in the research literature in comparison with 
Internet-based treatments. 
1.4.2.2 Treatment outcome 
1.4.2.2.1 Panic Disorder 
Internet-based guided-self help has been shown to be efficacious for anxiety disorders 
(Andersson, Bergström, Carlbring, & Lindefors, 2005), and more specifically for PD 
(Richards, Klein, & Carlbring, 2003).  
 
In an early randomised trial, Carlbring and co-workers (2001) evaluated Internet guided 
CBT-self-help for PD for the first time, by comparing it to a wait-list control condition. 
Participants received information about the trial through newspaper articles and could 
then apply to participate on a web-page. There they were filled out a web-based self-
diagnostic tool called the CIDI-SF (Kessler, Andrews, Mroczek, Ustun, & Wittchen, 
1998), and several self-rated questionnaires. No in-person interview was thus 
performed. The self-help programme consisted of six modules presenting well-known 
CBT principles; psychoeducation, breathing retraining, cognitive restructuring, 
interoceptive- and in-vivo exposure, and relapse prevention. Participants were guided 
through treatment by weekly brief e-mail contact with a therapist, who provided access 
to subsequent modules in a stepped fashion. 41 participants were randomised to either 
such Internet CBT or to a waiting list, and at post-treatment those in the treatment 
condition had improved significantly on self-report measures related to panic- and 
agoraphobic symptoms whereas participants in the control had not improved. However, 
no long-term follow-up was made, and PD diagnosis was thus determined by self-
report, and not in a clinical interview. 
 
To adequately obtain diagnosis, in-person clinical interviews were performed in a 
subsequent study (Carlbring, Ekselius, & Andersson, 2003). In this trial the aim was to 
examine the importance of the amount of therapist contact in Internet treatment, while 
comparing it to another evidence based treatment for PD, namely AR (Öst, 1987), 
adapted to an Internet format. The same CBT self-help programme as in the first trial 
was used. The results in the this study showed that, although not statistically 
significant, the AR treatment had larger ES than the Internet CBT (Cohen’s d=0.71 for 
AR and d=0.42 for CBT), probably because of the reduction in amount of guidance 
provided in this trial relative to the previous one. However, compliance to the treatment 
judged being a problem, in yet another study by the same group (Carlbring, et al., 2006) 
weekly telephone calls were added to Internet treatment (still including the same format 
with self-help, guided by therapist e-mail support) which resulted in better compliance 
and better, larger ES (with an average of Cohen’s d=1.2 on measures of anxiety and 
agoraphobic avoidance). Treatment effects were sustained at 9-months follow-up. In 
yet another recent open trial, the programme by Carlbring was evaluated in a 
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community setting in Norway (Nordgreen, et al., 2010) where 27 participants 
diagnosed with PD in an in-person diagnostic interview were eventually included. The 
average within-group effect size on panic- and agoraphobic questionnaires at post-
treatment was Cohen’s d=0.65 and at the 6-month follow-up it was d=0.50. The drop-
out rate was somewhat larger than in the earlier randomised studies. An analysis of 
predictors of outcome was also made in this trial that showed that a longer duration of 
PD was related to worse outcome.  
 
Study III, using a modified version of the programme developed by Carlbring, can be 
said to be a first open effectiveness evaluation in a regular clinical environment, 
complementing these earlier efficacy trials with self-recruited participants by Carlbring 
and co-workers. The importance of effectiveness (as opposed to efficacy) research will 
be elucidated below (1.5.1) 
 
In one trial by a British group (Schneider, Mataix-Cols, Marks, & Bachofen, 2005) the 
effect of two different Internet-administered programmes were compared for “phobic 
and panic disorders”. Thus participants were not exclusively PD-sufferers, and 
participants with social- and specific phobia were also included. Participants were, after 
an assessment interview by telephone, randomly assigned to receive either a 10-week 
exposure-based CBT programme (“Fearfighter”) or an equally 10-week long non 
exposure-based “minimal” CBT programme. Therapist support was given by telephone 
calls. After treatment both conditions showed significant and similar improvement. 
After a short 1-month follow-up, improvement was significantly greater in the exposure 
condition on half of the phobic-related self-report measures. In a very small open study 
by the same group (Kenwright, Marks, Gega, & Mataix-Cols, 2004), ten participants 
accessed the Fearfighter programme from home via the Internet, and improved 
significantly on self-report of phobic symptom severity. 
 
In two trials directly comparing Internet CBT with individual face to face CBT, these 
treatment formats were found to be equally efficacious (Carlbring, et al., 2005; 
Kiropoulos, et al., 2008). In the study by Carlbring and co-workers (2005) 49 
participants were after an in-person SCID-interview randomised to either 10 individual 
CBT sessions or 10 weeks of Internet CBT. The within-group ES at the 1-year follow-
up was Cohen’s d=0.80 for Internet CBT and d=0.93 for individual face-to-face CBT. 
In a subsequent study on predictors of treatment outcome on participants in this study 
(Andersson, Carlbring, & Grimlund, 2008) it was found that, in line with earlier 
research on predictors of outcome in traditionally administered CBT (Ramnerö & Öst, 
2004), agoraphobic avoidance at baseline was the strongest negative predictor of 
outcome. However, this was not the case for the Internet treatment. The authors hold 
that this can possibly be explained by the fact that the need of coming to a clinic in 
traditional CBT constitutes a too brusque agoraphobic exposure that may interfere with 
subsequent treatment, while participants in Internet CBT had an initially “smoother” 
encounter with treatment, which would allow them to subsequently profit more from it.  
 
Study IV, following Study III, can be seen as an effectiveness trial building directly on 
this efficacy trial of Carlbring and co-workers (2005) by comparing Internet CBT with 
live, group CBT in a psychiatric setting with predominantly referred patients.  
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In the trial by Kiropoulos and co-workers (2008) the 86 participants were, after an in-
person ADIS-IV-interview, randomised to either a 12 week Internet CBT-treatment 
called “Panic Online” or to a “gold standard” face-to-face CBT (Barlow & Craske, 
2000). At post-treatment 30.4% of the participants in the Internet CBT-condition and 
27.5% in the face-to-face condition achieved high end-state functioning. No long-term 
follow-up measurement was made in this trial. The same research group later 
examined, in a randomised trial, the importance of therapist competence (Shandley, et 
al., 2008). The same Internet CBT-programme was used in both conditions, but the e-
mail support was given either by clinical psychologists (n=43) or the patients general 
practitioner (GP; n=53), having received brief CBT training. No significant differences 
between the two treatment conditions were found at neither post-treatment or at the 6-
month follow-up on measurements of panic and related symptoms.  However, attrition 
was fairly high, and more patients dropped out to post-treatment in the GP condition 
than in the psychologist condition, the latter also having a statistically significant larger 
improvement on two quality of life-subscales. 
1.4.2.2.2 Depression 
A relatively large number of trials have evaluated Internet-based CBT for depression, 
but compared to the literature on PD, there are much larger conceptual and 
methodological differences across studies. In a meta-analysis by Andersson and 
Cuijpers (2009a) on Internet- or computerised CBT for depression an overall between-
group (comparison with control) effect size of d = 0.41 was found. However, a 
significant difference was found between those interventions providing therapist 
support (d=0.61) and those not providing support (d=0.25), which is in line with a 
previous meta-analysis (Spek, Cuijpers, et al., 2007).  
 
In several trials covered in this meta-analysis an in-person diagnostic clinical interview 
has not been used. As in Study I, assessment was instead carried out by way of online 
forms. The only Internet-based study that did include an in-person interview was 
conducted by Spek and co-workers (2007), targeting sub threshold depressive 
symptoms in people over 50 years of age. In this study, after this clinical interview 
establishing diagnosis, participants were randomised to either Internet CBT (however 
without therapist support), CBT group treatment (Lewinsohn, et al., 1984) or to a wait-
list group. Both active treatment conditions were significantly more effective in 
reducing sub threshold depressive symptoms than the waiting-list, results which were 
maintained for the Internet CBT but only partially for the group CBT at 12-month 
follow-up (Spek, Cuijpers, et al., 2008). In a subsequent study analysing predictors of 
treatment outcome, high pre-treatment depression scores, female sex and less neurotic 
personality traits were associated with better treatment outcome in both Internet- and 
group treatment (Spek, Nyklicek, Cuijpers, & Pop, 2008). 
 
In a study by Warmerdam and co-workers (2008), included in the meta-analysis 
mentioned earlier, Internet-based CBT was compared to Internet-based problem 
solving therapy (PST) and a wait-list control condition. Participants were recruited 
through media and no in-person assessment was made. The 8-week CBT self-help 
programme was based on behavioural principles (Lewinsohn, et al., 1984) and the 5-
week PST programme was based on self-examination bibliotherapy as developed by 
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Bowman (1995). Participants received both automated as well as personal e-mail 
feedback from therapists, amounting to a total of 100 minutes for PST and 160 minutes 
for CBT. Despite a fairly elevated drop out rate and no long-term follow-up, the study 
provided some evidence for treatment efficacy, when 12-weeks after baseline both 
treatment groups showed medium effect sizes on measures of depressive symptoms 
compared to wait-list (CBT: Cohen’s d = 0.72, PST: Cohen’s d = 0.66) 
 
In another trial covered in the meta-analysis by the same Dutch group (van Straten, 
Cuijpers, & Smits, 2008), an Internet-self help programme (with e-mail support) based 
on problem solving therapy was compared with a wait-list control condition, for 
participants with depressive and anxiety symptoms as well as work-related stress. Post-
treatment data obtained from 83% of the participants showed that the intervention 
group had improved significantly more than those in the control group on measures of 
depressive symptoms. 
 
As mentioned, in many studies on Internet CBT for depression, including several of 
those included in the meta-analysis by Andersson and Cuijpers, no formal diagnostic 
procedure is performed, and in some no therapist contact is established neither. The 
results from such “open access” interventions shows that they are only to a small 
degree, or not at all, more effective than psychoeducation only (Christensen, Griffiths, 
& Jorm, 2004; Christensen, Griffiths, Mackinnon, & Brittliffe, 2006; Mackinnon, 
Griffiths, & Christensen, 2008; Patten, 2003). Because of high attrition rates in these 
studies, it is difficult to draw well-founded conclusions. In the results from two other 
studies, included in Andersson and Cuijpers meta-analysis, the relation between 
therapist guidance and efficacy became especially clear, the first trial with no support 
not achieving significant reduction in depressive symptoms (Clarke, et al., 2002), 
whereas once support was introduced, the intervention did show effect (Clarke, et al., 
2005). A third trial by the same group (Clarke, et al., 2009), again comparing pure 
(unguided) Internet self-help with a treatment as usual condition, yielded a small 
between group effect size (Cohen’s d=0.20) 
 
From a broader public health perspective it may however be unfair to criticise open-
access interventions for their high attrition and generally low effects, since their aim 
have not been to deliver specific psychiatric treatment to diagnosed patients, but rather 
to be a tool for the prevention of depression and anxiety in the community (Andersson, 
2009). In this perspective, high-rates of attrition is probably inevitable and may not be 
contradictory to its goal of providing broad community health prevention services. 
 
There are a number of more recent trials on Internet CBT for depression not included in 
Anderssons and Cuijpers meta-analysis worth mentioning because they show 
promising results. 
 
In a large trial conducted within the general practice health care system in Great Britain 
by Kessler and co-workers (2009) an online, real-time CBT intervention (thus not 
guided self-help) was compared to usual care by a general practitioner. In this trial, an 
in-person assessment of diagnosis and symptom severity was made, followed by 10 55-
minute sessions of online text-based interaction with a therapist. After treatment, the 
amount of patients recovered from depression was significantly higher in the treatment 
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group (38%) than in the usual care control group (23%), which also was retained at the 
8-month follow-up (42% and 26% respectively). 
 
In a second recent trial not included in the mentioned meta-analysis, Jeroen Ruwaard 
and co-workers (2009) randomised 54 participants with moderate depression to either 
Internet CBT or a wait-list control condition. The Internet CBT consisted of a web-
based self-help programme that was accompanied by e-mail support by a therapist and 
thus resembled the treatment of Study I. However, it was both longer (on average 16 
weeks) and included considerably more therapist time (on average more than 7 hours 
per therapist and patient) than in Study I. Participants were recruited through 
information in a newspaper. No in-person diagnostic procedure was performed, and 
assessment was based solely on self-report. At post-treatment, while the control group 
also got better, improvement was greater in the treatment condition, with an between-
group effect size of Cohen’s d=0.9 (depression measures pooled together) and gains 
were maintained at the 18-month follow-up, when the control group also had received 
treatment. In this trial potential predictors of outcome were also examined, and besides 
the methodologically expected positive correlation between pre-treatment depression 
severity and post-treatment improvement, the only (negative) correlation found was 
between presence of antidepressant pharmacological treatment and improvement at 
follow-up. 
 
In a third recent trial (Meyer, et al., 2009) an open Internet-based treatment package 
including CBT-principles was found to be efficacious for participants recruited from 
depression discussion groups on the Internet. Even though no therapist support was 
given, attrition was “only” 45%, possibly because there was a clear treatment structure 
with deadline for treatment completion (Nordin, et al., 2010) and participants had 
scheduled interactions, however automated by the programme. 
 
In a fourth large study by de Graaf and co-workers (2009), not included in the 
previously mentioned meta-analysis, 303 participants recruited from the community 
were, after computerised assessment and self-diagnostics, randomised to either Internet 
CBT (without therapist support), treatment as usual (TAU) in a general practitioner 
(GP) setting, or TAU + Internet CBT. The Internet CBT programme was a Dutch 
adaptation of the previously mentioned Coping With Depression course by Lewinsohn. 
TAU included GP appointments and pharmacological treatment when indicated. Up to 
a 6-month follow-up, dropout was only 9.2% in this large sample. At the 6-month 
follow up, all conditions improved, showing within group effect sizes of Cohen’s 
d=0.86, d=0.81 and 0.89 respectively. However, between group effect sizes were near 
zero, and thus no significant differences were found between conditions. The authors 
conclude that the fact that no guidance was given probably accounts for the relatively 
moderate effect, and that there was no superiority of CBT over TAU. 
 
Finally, recently an Australian trial was published (Perini, Titov, & Andrews, 2009) 
which in its design is much more similar to Study I than the previously reviewed 
studies. In this trial participants were recruited through a website where an automated 
screening was made. Followed a telephone-interview that established diagnosis of 
depression by way of MINI (Sheehan, et al., 1998). A total of 45 participants met all 
inclusion criteria and were randomly assigned to either Internet guided self-help or to a 
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waitlist control condition. The 9-week Internet CBT consisted of 6 modules, homework 
assignments, participation in a discussion group, and obligatory e-mail contact with the 
therapist. The average therapist time used per patient during treatment was 111 
minutes. No follow-up measurement was made in this trial, but at least at post-
treatment the intervention was shown to be effective, with an within-group effect size 
on the BDI of Cohen’s d=1.15 and a between-group effect size on the same measure of 
d=0.63. 
 
Yet two more trials by our group have evaluated a revised version of the treatment 
programme (Andersson, Bergström, Holländare, Lenndin, & Vernmark, 2007) that first 
was developed for Study I. In the first one (Vernmark, et al., 2010), the guided self-
help programme (n=29) was compared to individualised e-mail therapy (n=30) and to 
an untreated wait-list condition (n=29). Drop-out rate was low, with 84% providing 
both post-treatment and 6-month follow-up assessments. As mentioned, the model of 
guided self-help was equivalent to the one used in Study I. The content of the e-mail 
therapy overlapped substantially with the self-help used in this condition, but the 
possibility of individualisation from the therapist was larger, both in terms of feedback 
given and in terms of home-work assignments. A specific therapist manual was 
developed for this purpose. Average therapist time spent per participant was 53 (SD= 
28) minutes in the guided self-help condition and 509 minutes (SD = 176) in the e-mail 
therapy condition. No significant differences in treatment outcome were found between 
the two active treatments neither at post-treatment nor at follow-up and both were 
superior to the waiting-list control group. However, individualised e-mail therapy 
demanded nearly 10 times more therapist time than did the guided self-help treatment, 
the latter thus being more cost-effective. 
 
Relapse is unfortunately a common problem after discontinued treatment, not only after 
pharmacological but also after cognitive behavioural treatment (Vittengl, et al., 2007). 
In the second study by our group using a revised version of the programme developed 
for Study I, the guided self-help format was used in a trial to prevent relapse in 
depression (Holländare, Johnsson, et al., 2010). After recruiting participants through 
newspapers, participants went through a telephone interview based on the SCID-I 
(First, Gibbon, Spitzer, & Williams, 1996). The inclusion criteria were that the 
participant must have had at least one major depressive episode (MDE) during the last 
five years, but not currently be fulfilling criteria for an MDE. Moreover, participants 
had to have residual mild depressive symptoms, as defined by having a score of 
between 7 and 19 on the Montgomery Åsberg Depression Rating Scale – Self-rated 
(MADRS-S) (Holländare, Andersson, & Engström, 2010; Holländare, Askerlund, 
Nieminen, & Engström, 2008; Svanborg & Åsberg, 2001). After inclusion participants 
were randomised to either Internet CBT (n=38) or to a wait-list control group (n=39) 
for 10 weeks. Results showed that, in the Internet CBT group no participant relapsed 
during the 10 weeks of treatment, whereas in the control condition, 10 participants 
relapsed (25.6 %) during this time. This difference between the groups was statistically 
significant. However, no significant difference was seen in the reduction of depressive 
symptoms as measured by the BDI or MADRS-S. At six months after the intervention, 
there was still a significant difference in relapse rates between conditions, but again, no 
significant differences in levels of depressive symptoms. The latter finding is possibly 
due to low power and a statistical “floor effect” since these participants, having 
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recovered from a MDE, had relatively low symptoms levels. This was the first study to 
show that an Internet CBT intervention for depression may prevent relapse in a MDE. 
It is an area that merits further research attention. 
 
In conclusion these two studies, building upon the programme developed for Study I, 
both replicates this study’s findings and shows that adding considerably more therapist 
time does not enhance treatment outcome. Moreover, it gives tentative evidence that 
Internet-based CBT is effective in reducing relapse rates in depression. 
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1.5 FROM DEVELOPMENT TO DEPLOYMENT 
1.5.1 Efficacy and effectiveness 
Treatment outcome research, and the field of guided self-help and Internet treatment is 
no exception, can be construed as having three essential steps; efficacy, effectiveness 
and implementation or dissemination (Schoenwald & Hoagwood, 2001). One could 
argue that, up to until recently, treatment outcome trials have almost exclusively been 
those of establishing efficacy, as evident in the field of Internet-based treatment by the 
review of outcome studies made above. The dominant line of research has thus been 
the evaluation of treatments in carefully controlled settings with selected (usually self-
recruited) participants, forming the Empirically Supported Treatment (EST) 
(Chambless & Hollon, 1998; Lutz, 2003). Evaluations of such ESTs treatments in 
“usual care” settings have largely been lacking. This in turn has evoked much criticism 
within the research literature, many claiming that ESTs do not tell us anything about 
“real life” psychological treatment (Shadish, Matt, Navarro, & Phillips, 2000).  
 
Recent years have however seen a strong gain in the interest for effectiveness research 
(Hoagwood, Hibbs, Brent, & Jensen, 1995) while dissemination research, that is the 
study of which practices should be adopted to reach the goal of actual deployment in 
usual-care services, is within the field of psychological treatment still in its very 
infancy (Garland, Hurlburt, Brookman-Frazee, Taylor, & Accurso, 2009). 
 
While the goal within efficacy research is to maximise internal validity, that is the 
degree to which one can determine the causal factors involved in the observed change 
during treatment, the goal within effectiveness research is rather to maximise external 
validity, that is the degree to which the results are representative for usual care contexts 
(Stewart & Chambless, 2009). Of course there is no absolute and mutually exclusive 
distinction between efficacy- and effectiveness research, but rather a continuum 
between the poles of maximum internal- and external validity. In effectiveness trials 
patients are preferably referred in a regular manner to treatment (and not solicited by 
the researcher), extensive exclusion criteria are not used, those performing treatment 
should preferably be regular staff not specially trained for participation in the trial and 
the patients in the trial should not receive more special attention or additional treatment 
interventions in comparison to what patients normally would receive (Shadish, et al., 
1997).  
 
In a meta-analysis by Shadish and co-workers (2000) 90 effectiveness studies of 
psychotherapy were included and the main conclusion was that therapies are effective 
over a large range of clinical settings, with medium to large effect sizes. Effects were 
shown to increase with larger therapy dose and when outcome measures are specific to 
treatment.  
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In a more recent meta-analysis that included subsequent studies carried out in clinically 
representative settings but not covered by the meta-analysis by Shadish, Stewart and 
Chambless (2009) included 56 published effectiveness trials of CBT for anxiety 
disorders. In this meta-analysis the average within-group effect size for studies 
measuring PD symptoms was Cohen’s d=1.02.  
1.5.2 Cost-effectiveness 
Another aspect of clinical research receiving increasing amount of attention in the 
literature is cost-effectiveness analysis (Drummond, Sculpher, Torrance, O'Brien, & 
Stoddart, 2005). In the light of the issues of dissemination and accessibility of 
psychological treatments raised above, formal evaluations of the relation between costs 
of treatment delivery and effects of treatment are crucial.  
 
The basic principle of cost-effectiveness analysis is to relate costs to effectiveness and 
to thus obtain a cost-effectiveness ratio. More specifically, one uses the term 
incremental cost-effectiveness ratio (ICER) (Wang & Zhao, 2006) which is a measure 
of the additional cost of a new treatment (compared to an alternative, or no treatment) 
for each additional unit of effectiveness. The measurement in effect is in these types of 
analysis often made in so-called quality-adjusted life years (QALYs) (Broome, 1993), 
but can also be any measure of effect, such as in Study IV, were the clinician rated 
measure PDSS (Shear, et al., 1997) was used for this purpose. 
 
The cost-effectiveness of computer- or Internet-based treatment is not well known 
(Kaltenthaler, et al., 2006; Palmqvist, Carlbring, & Andersson, 2007), which also has 
been specifically pointed out by SBU, The Swedish Council on Health Technology 
Assessment, in a report on the evidence of computerised and Internet-based CBT 
(Linton, 2007). However, in a promising first study by McCrone and co-workers 
(2004) of the computerised CBT programme “Beating the Blues” for anxiety and 
depression discussed earlier, a high probability of the intervention to be cost-effective 
was found, even when a low monetary value was set to each unit of symptom 
improvement. 
1.5.3 Development of studies in the thesis 
As already touched upon, this thesis reflects the move that research on computerised 
and Internet-based guided self-help has taken during the latest 10 years, shifting focus 
from purely efficacy research to also incorporating the themes of effectiveness, cost-
effectiveness and implementation in regular care.  
 
In Study I, being an early trial, the aim of the study was to examine the efficacy of 
Internet-based CBT for depression, comparing it with a condition of receiving only 
participation in a discussion forum, but no treatment. It was thus not carried out in a 
psychiatric setting and the participants treated for depressive symptoms were neither 
referred patients nor accessed in a regular clinical interview.  
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Study II examined predictors of outcome in patients from Study I. 
 
In Study III, being a later study conducted after the efficacy of Internet-based CBT for 
PD had already been established in numerous trials as reviewed above, the aim was to 
evaluate Internet-based CBT for PD in a regular psychiatric setting with patients 
referred for treatment and not recruited by advertisement. The study represents a 
transition into the psychiatric milieu with the introduction of rigorous psychiatric 
diagnostic assessment and also constitutes a feasibility study, examining how Internet-
based treatment could be integrated in a psychiatric environment.  
 
In the much larger Study IV, that followed Study III, the primary aim was to compare 
the effectiveness of Internet-based CBT with group CBT for PD, in a psychiatric 
setting with referred patients. This was the first time this was done in a RCT for any 
psychiatric disorder. Such a move into the domain of effectiveness research is 
important, if the step into real-life implementation of novel treatments is to be made, 
and thus if the goal of guided self-help and Internet treatment is truly to be achieved – 
that is, that of making evidence based psychological treatment accessible to a much 
larger number of people. The secondary aim of Study IV was to evaluate and to 
compare the cost-effectiveness of Internet- and group treatment.  
 
Studies I through IV are outlined below. 
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2 THE EMPIRICAL STUDIES 
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2.1 STUDY I. INTERNET-BASED SELF-HELP FOR 
DEPRESSION: A RANDOMISED CONTROLLED 
TRIAL 
2.1.1 Aims 
The aim of this study (Andersson, Bergström, Holländare, et al., 2005) was to 
investigate the effects on depressive symptoms of Internet-based CBT (self-help with 
short e-mail support) including participation in a monitored discussion group, 
compared with participation in the discussion group only (Houston, Cooper, & Ford, 
2002). 
2.1.2 Methods 
Participants were recruited through a press release and subsequent articles in Swedish 
newspapers which included the address of a website that provided general information 
and instructions on how to proceed to complete a computerised version of the 
Composite International Diagnostic Interview Short-Form (CIDI–SF) (Kessler, et al., 
1998) which renders a diagnosis of major depression and other main comorbid 
diagnoses. 
 
Participants also completed the Beck Depression Inventory (BDI) (Beck, Ward, 
Mendelson, Mock, & Erbaugh, 1961) and the MADRS–S (Montgomery & Åsberg, 
1979) on the website. Besides depression self-ratings participants completed a form 
requesting their e-mail address, information on their age, gender, the size of town in 
which they lived, the three first digits of their postal code (to obtain an estimation of 
geographical spread within Sweden), education, occupation, medication and contacts 
with healthcare professionals. 
 
To be included in the trial, the participants had to have a probability of 55% or more for 
the diagnosis of major depression (on the CIDI-SF), have a total score on the MADRS-
S between 15 and 30 (mild-to-moderate depression; including a score of less than 4 on 
item 9 - zest for life), not suffer from psychosis (according to medication status) nor 
bipolar disorder, not having begun antidepressant medication within one month prior to 
start of the trial (or changed in dosage during that time), not have a history of 
cognitive–behavioural therapy for depression, be 18 years or older, be prepared to work 
with the self-help programme several hours each week, and have had completed pre-
treatment assessment. Participants were then randomised by an independent person by 
way of a random number procedure. 
 
The principal outcome measure of depression was the 21-item BDI (Beck, et al., 1961) 
and the results are based upon this instrument. Besides the MADRS-S (9 items), the 21-
item Beck Anxiety Inventory (BAI) (Beck, Epstein, Brown, & Steer, 1988) and the 
Quality of Life Inventory (QOLI) (Frisch, Cornell, Villanueva, & Retzlaff, 1992) were 
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also administered. The cognitive–behavioural self-help programme was based on 
Beck’s CT, as presented in the self-help book “Feeling good” (Burns, 1999), and on 
behavioural activation (BA) as presented in the self-help book “Control your 
depression” (Lewinsohn, et al., 1986) and in the book “Depression in context” (Martell, 
et al., 2001). The material (presented in Swedish) consisted of 89 pages of text, divided 
into five modules: introduction; behavioural activation; cognitive restructuring; sleep 
and physical health; and relapse prevention and future goals. The sleep module was 
based on a programme for insomnia (Ström, Pettersson, & Andersson, 2004). The 
amount of time advised for completion of all five modules was 8 weeks. However, the 
mean time for completion was 10 weeks. The therapist time spent on each participant 
was estimated to be 2 hours in total, including screening, responding to e-mails and 
monitoring the discussion group. 
 
For ethical reasons the control group participants were given access to the treatment 
modules after the intervention group had finished their treatment. Participants were 
contacted by e-mail and asked to fill in the questionnaires again on the internet 6 
months after the treatment had ended. All randomised participants with follow-up data 
were included in the analyses regardless of how many treatment modules they had 
completed. This could also be referred to as ‘intention to treat’, as we included all those 
who provided post-treatment data. However, for the main outcome measure we also 
calculated results on a last observation carried forward basis, replacing missing values 
post-treatment with pre-treatment values.  
 
Of the 343 persons who completed the inclusion forms, 117 (34%) were included; 226 
persons were excluded from the study. The most common reason for exclusion was risk 
of suicide (n=77; measured by item 9 on the MADRS-S) and not being mildly-to-
moderately depressed (n=67; measured by total MADRS-S score).  
2.1.3 Results 
Post-treatment measures were completed by 36 participants in the treatment group and 
49 in the control group. These 85 participants were included in all statistical analyses 
regardless of the amount of treatment received. In total the rate of withdrawal from the 
treatment was 27% (32 of 117). 
 
Analyses of variance with a 2x2 design (one group factor and one repeated-measures 
factor) resulted in significant interactions for the BDI (F(1,83)=14.22; p<0.001), 
MADRS–S (F(1,83)=7.77; p=0.007) and BAI (F(1,83)=5.72; p=0.019). These 
interactions reflect differences in change scores between the active treatment and the 
control condition. The corresponding effect sizes (Cohen’s d between groups at post-
treatment) were 0.94 for the BDI, 0.79 for the MADRS–S and 0.47 for the BAI. 
Replacing missing values with the last observation available for the full sample of 117 
participants did not alter the results on the main outcome measure BDI. 
 
Participants in the intervention group normally reached at least the fourth module, with 
65% completing all modules. The average number of modules completed was 3.7 
(SD=1.9). The number of modules completed was negatively correlated with post-
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treatment BDI scores (Spearman’s r=–0.33, p<0.05). Activity in the discussion group 
was not correlated with improvement in the treatment group. 
 
At the 6-month follow-up, all participants had received treatment and 71 of them (all in 
the treatment group and 35 in the control group) completed the questionnaires again, 
yielding a 16% rate of participants lost to follow-up from post-treatment (0% in the 
treatment group and 29% in the control group). Analysis of the difference between the 
groups at follow-up revealed no statistically significant difference. However, both 
groups demonstrated significant effects indicating that treatment gains were maintained 
to follow-up. As the control group also had received treatment, we expected changes 
between post-treatment and follow-up for this group, but no difference for the treatment 
group. This assumption was confirmed by means of paired t-tests for the BDI, 
MADRS–S, BAI and QOLI (all p values were less than .05 in the control group and 
more than .05 in the treatment group). 
2.1.4 Discussion 
This randomised controlled trial of Internet-delivered self-help with brief therapist 
support based on CBT yielded two major results. First, the active treatment, which 
included standard CT approaches and behavioural activation, resulted in decreased 
depressive symptoms immediately after treatment and at the 6-month follow-up. 
Benefits were also observed regarding anxiety symptoms and quality of life. Second, 
only participation in a web-based discussion group had no effect on depressive 
symptoms, which is in contrast with a study showing some benefits from participation 
in an Internet support group (Houston, et al., 2002).  
 
There was a differential rate of withdrawal between the two groups, and judging from 
the comments we received, some perceived the text and the exercise as too demanding. 
A solution to this is to adjust the text, and to allow a longer treatment period. Although 
self-report was used to obtain a likely diagnosis using DSM criteria, no formal 
diagnosis was made in an interview. Hence, it is possible that people with depression 
were excluded and people without depression were included. However, this is not very 
likely, particularly the latter possibility of including people who would not fulfil DSM 
depression criteria in a structured interview. Research on Internet-based self-help for 
depression would benefit from clear-cut diagnoses before initiation of treatment; in our 
study, we did not use a clinician-administered interview. 
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2.2 STUDY II. DELIVERING CBT FOR DEPRESSION 
VIA THE INTERNET. PREDICTING OUTCOME AT 
6-MONTHS FOLLOW-UP 
2.2.1 Aims 
In this study (Andersson, Bergström, Holländare, Ekselius, & Carlbring, 2004) we 
returned to Study I to analyse predictors of outcome at 6-month follow-up. This is 
crucial because it cannot be inferred that the same outcome predictors will be relevant 
in Internet based treatment and in face-to-face therapy. 
2.2.2 Methods 
See Study I for a more complete description of methods used in the randomised trial. In 
this study we used the data obtained at the 6 month follow up. In total, 71 participants 
completed the 6-month follow-up (84% of the original sample). Mean age of the 
participants was M=37 years (SD = 11), and there were 79% females.  
 
As mentioned earlier in Study I the principle outcome measure of depression was the 
BDI (Beck, et al., 1961); in addition the MADRS-S (Mattila-Evenden, Svanborg, 
Gustavsson, & Åsberg, 1996; Montgomery & Åsberg, 1979) was administered. For 
predictor analyses, we calculated a change index of these two measures. In order to 
estimate if pre-treatment self-reported levels of depression, anxiety and quality of life 
were associated with outcome, we used pre-treatment scores from the BDI, MADRS-S, 
BAI (Beck, et al., 1988) and the QOLI (Frisch, et al., 1992). Other pre-treatment 
predictors were demographic and clinical data such as age, gender, education (in 5 
categories), and number of episodes of depression before entering the trial. 
 
Results were analysed by means of multiple regression analysis, entering predictor 
variables simultaneously. In addition, Pearson correlations and Spearman rank 
correlations were calculated when needed. Given the common practice of using 
correlation coefficients (raw) as estimates of effect size (Rosenthal, 1991), we decided 
to present results from regression analyses and raw correlations. For the first set of 
regression analyses, we used the change index as dependent variable and the 
demographic and clinical factors as predictors. For the second set we used follow-up 
levels of the BDI and MADRS as dependent variables and pre-treatment levels of these 
two questionnaires, of the BAI, and of the QOLI as predictor variables. 
2.2.3 Results 
The mean change score (e.g., improvement in raw scores from pre-treatment to follow-
up) for the BDI was M = 7.7 (SD = 9.8), and M = 6.5 (SD = 8.7) for the MADRS-S. 
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For the BDI change score, the number of previous episodes of depression was 
associated with worse outcome. This was also confirmed in the regression analysis [t = 
–2.1, p < .05, beta = –0.25]. The latter correlation was also significant when using 
Spearman’s signed rank correlation (rho = –0.24, p = .04). The other demographic and 
clinical factors included in the regression were not associated with the outcome (all p’s 
> 0.24). The regression analysis for the MADRS-S change score did not result in any 
significant finding. 
 
For the second set of analyses, the BDI follow-up score was used as dependent variable 
and pre-treatment scores as predictors. While the overall regression was statistically 
significant (p = .008), none of the predictor variables reached statistical significance on 
their own. A different picture was seen when the MADRS-S was used as dependent 
variable as QOLI [t = –2.1, p < .05, beta = –0.29], BAI and MADRS-S pre-treatment 
levels [t = 2.4, p < .05, beta = 0.29] were associated with outcome. 
2.2.4 Discussion 
The main result of this study was that only weak associations between different 
presumed predictors and outcome were found, with the exception of pre-treatment 
levels of depression, anxiety and quality of life. This finding was expected, since higher 
self-reported severity has previously been seen to be associated with poorer outcome 
(Hamilton & Dobson, 2002). Albeit weak, a statistically significant correlation was 
found in the same direction showing that more episodes of depression was associated 
with worse response to the guided self-help treatment.  
 
There are, of course, several methodological issues that should be commented on. We 
only analysed few possible predictors and with a relatively low statistical power. In 
future studies, it would be interesting to investigate the predictive power of social 
support networks and to account in detail for medication, e.g. SSRIs. In the present 
study we only asked about medication in general which was unrelated to outcome. In 
addition to adopting a multivariate model approach, we investigated each possible 
predictor separately, but did not adopt a stepwise approach. The use of change scores as 
dependent variables has been questioned (Steketee & Chambless, 1992), although the 
alternative of using residual change scores has been questioned also as being less 
comprehensible from a clinical point of view. Another objection made by Steketee and 
Chambless (1992) was that analyses of outcome predictors often consist of ‘fishing 
expeditions’, without clear preconception of what to look for. Admittedly, the data in 
the present study was not collected bearing treatment outcome predictors in mind. Still, 
given the lack of knowledge in this field, we believe that exploratory analyses were 
justified. 
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2.3 STUDY III. AN OPEN STUDY OF THE 
EFFECTIVENESS OF INTERNET TREATMENT FOR 
PANIC DISORDER DELIVERED IN A 
PSYCHIATRIC SETTING  
2.3.1 Aims 
The aim of this study (Bergström, et al., 2009) was to conduct an effectiveness trial 
evaluating an Internet-based treatment (including brief therapist contact) for PD in a 
regular psychiatric setting with patients referred for treatment and not recruited by 
advertisement. The treatment was specifically developed and adapted for the hospital 
IT environment and therapists were clinical psychologists working with anxiety 
disorders. Moreover, psychiatrists diagnosed patients for treatment as part of their 
regular practice.  
2.3.2 Methods 
Patients with presumed PD referred to the Anxiety Disorders Program at the Psychiatry 
Center Karolinska, Stockholm, were assessed in an in-person clinical interview. 
Twenty consecutive patients meeting the inclusion criteria were included during the 
study period. 
 
Within the frame of a regular psychiatric assessment, a structured clinical interview 
was performed using the MINI (Sheehan, et al., 1998) as well as an analysis of blood 
samples to rule out a possible physical aetiology of the anxiety symptoms (e.g. 
hyperthyroidism or anemia). To be included in the study, participants had to meet the 
following criteria: 1) fulfil the DSM-IV (American Psychiatric Association, 2000a) 
diagnosis of PD with or without agoraphobia 2) PD being the primary diagnosis, 3) if 
on medication for PD, the dosage had to be stable for 2 months before entering the 
study. Patients were not excluded on the basis of comorbid axis I or axis II diagnosis, 
as long as the PD was considered the primary diagnosis. All patients were recruited 
through referrals.  
 
The self-help programme was divided into 10 modules, delivered during a 10-week 
treatment phase. The programme consisted of five broader themes: psychoeducation, 
cognitive restructuring, interoceptive and in vivo exposure, and relapse prevention. 
Each patient was required to complete a module to get access to the following one after 
e-mail interaction with the therapist. Each feedback required approximately 5-10 min 
of the therapist's time. The treatment modules overlap in part with the programme 
developed by Carlbring and co-workers (2001), but some content as well as the 
sequencing of modules was slightly different. 
 
 44 
The first main outcome measure in the study was the Panic Disorder Severity Scale 
(PDSS) (Shear, et al., 1997), which is a clinician-administered instrument assessing the 
number of panic attacks, limited symptom attacks, agoraphobic avoidance, somatic 
sensitivity and PD-specific effects on global functioning. Treatment response was 
defined as the proportion of patients showing at least a 40% decrease from baseline on 
the PDSS, as in conjuncture with earlier trials on PD (Barlow, et al., 2000; Milrod, et 
al., 2007).  
 
The second main outcome measure was the self-report measure Mobility Inventory for 
agoraphobia (MI) (Chambless, Caputo, Jasin, Gracely, & Williams, 1985). Other self-
report measures were the Beck Anxiety Inventory (BAI) (Beck, et al., 1988), Beck 
Depression Inventory (BDI) (Beck, et al., 1961), Montgomery-Åsberg Depression 
Rating Scale—Self-rated (MADRS-S) (Svanborg & Åsberg, 2001), and the Hospital 
Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983). All measures were 
obtained at pre-, post-treatment and at follow-up, with the exception of the HADS, 
which also was completed in association with each module. 
 
Of the 20 consecutive patients included in the study, nine were men and 11 were 
women. Mean age was M=34 years (SD=7.0). Two patients dropped out before post-
treatment and yet another before the 6-month follow-up. Outcome data were included 
in the statistical analysis regardless of the amount of treatment received, on an 
intention-to-treat basis (Newell, 1992). 
2.3.3 Results 
Using last observation carried forward (LOCF), all 20 patients were included in the 
statistical analyses. Following the procedures recommended by Rosenthal & Rosnow 
(1991), we calculated composite scores for the main outcome measures (e.g. PDSS and 
MI scales) by converting to Z-scores for each measure and then calculating the mean 
for this composite score.  
 
A repeated-measure analysis of variance (ANOVA) showed a significant repeated-
measures effect [F(2,38) = 22.2, p<0.0001], which was followed by Bonferroni 
corrected t-test showing a decrease from pre- to post-treatment (p<0.0001), and 
between pre-treatment and follow-up (p<0.0001). There was no statistically significant 
change between post-treatment and follow-up. For the individual outcome measures 
dealing with PD the same outcome was obtained with main effects of time and post-hoc 
Bonferroni-corrected t-tests showing reductions on the PDSS and on the MI-scales (all 
p<0.001). 
 
Using the criteria for treatment response (i.e. the proportion of patients showing at least 
a 40% drop from baseline on the PDSS), the proportion of responders (still on an 
LOCF-basis) was 75% at post-treatment and 70% at 6-month follow-up. 
 
The secondary outcome measures showed repeated-measures effects for the BAI 
[F(2,38) = 15.0, p<.0001], the HADS scales of anxiety [F(2,38) = 26.7, p<.0001] and 
depression [F(2,38) = 14.01, p<.0001], MADRS [F(2,38) = 10.3, p<
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for the BDI [F(2,38) = 11.4, p<.0001]. All post-hoc tests showed the expected result of a 
reduction between pre- and post-treatment, and between pre-treatment and follow-up. 
 
The mean number of modules completed (out of 10 in total) for all 20 patients were 7.8 
(SD=2.4) within the intended 10-week time frame. The average therapist time spent per 
patient and week was 11.4 min. 
2.3.4 Discussion 
The results of the present study suggest that Internet-based treatment within regular 
psychiatric care is effective for patients with PD referred from primary care and 
psychiatric outpatient settings. Both clinician- and self-rated measures showed 
significant improvements on PD-related symptoms as well as comorbid depressive 
symptoms. 
 
Clinical trials showing the efficacy of CBT-based interventions are sometimes 
criticized for having too strict inclusion criteria and for treating less severe patients (for 
example less agoraphobic patients with little or no comorbidity as well as relatively 
short clinical history) in highly specialized university settings (Westen, Novotny, & 
Thompson-Brenner, 2004). This study evaluated Internet-based CBT within a regular 
psychiatric setting with consecutive referred patients, all of them agoraphobic with a 
mean clinical history of PD of several years. Twenty-five per cent of patients had at 
least one comorbid anxiety disorder and 20% had comorbid depression. Moreover, 
70% of patients were on medication for their anxiety and/or depression. Therefore, we 
believe that our sample is in several important aspects representative of a clinical PD 
population within a regular care setting. 
 
An obvious weakness of the study was that there was no control condition. However, 
earlier studies (Carlbring, et al., 2006; Carlbring, et al., 2001) have shown that the 
control group only shows a negligible change in panic and anxiety symptoms from pre- 
to post-test. The within group effect sizes observed in the present study are in line with 
those shown in earlier studies of Internet-based treatment of PD (Spek, Cuijpers, et al., 
2007) as well as those in studies evaluating face-to-face CBT (Taylor, 2000). 
 
In conclusion, the results from this study provide evidence to support continued use and 
development of Internet-based treatment for PD, also in traditional psychiatric care. 
However, an evaluation comprising a direct comparison with traditional CBT within a 
regular psychiatric setting should be made. The actual cost-effectiveness of such a 
treatment should also be evaluated more closely, specifically in relation to traditional 
psychological treatment. 
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2.4 STUDY IV. INTERNET- VERSUS GROUP-
ADMINISTERED COGNITIVE BEHAVIOUR 
THERAPY FOR PANIC DISORDER IN A 
PSYCHIATRIC SETTING: A RANDOMISED TRIAL 
2.4.1 Aims 
As noted earlier, the distinction between efficacy and effectiveness is regarded as 
important in treatment outcome research. In this study (Bergström, et al., 2010) the aim 
was firstly to compare Internet-based CBT with group CBT for patients diagnosed with 
panic disorder in a regular psychiatric setting. Secondly, our aim was also to evaluate 
the cost-effectiveness of Internet-based CBT in relation to the more traditional group 
CBT, which is currently considered to be the most cost-effective psychological 
treatment commonly used in clinical settings for PD.  
2.4.2 Methods 
Patients were consecutively referred for participation in the study from either 
psychiatric out-patient clinics or general practitioners. A third of patients were self-
referred to the clinic. After being interviewed by a research nurse in a short telephone 
screening interview, the patient was assessed in an in-person structured clinical 
interview conducted by a psychiatrist. The diagnostic part of the clinical interview was 
based on the M.I.N.I. (Sheehan, et al., 1998).  
 
To be included in the study the patients had to meet the following criteria: 1. Fulfil 
DSM-IV criteria for PD, 2. Have PD as primary diagnosis, 3. Be above 18 years of age, 
4. Not suffer from severe depression or suicidal ideation, 5. If taking prescribed drugs 
for panic disorder, having had a constant dosage for 2 months prior to commencing 
treatment in the study, 6. Not undergoing other CBT. 
 
The primary outcome measure was the PDSS (Shear, et al., 1997), described previously 
(Study III). Other outcomes measures used were the clinician administered Clinical 
Global Impression Scale (CGI) (Guy, 1976) and MADRS (Montgomery & Åsberg, 
1979), as well as the self-report measures Anxiety Sensitivity Index (ASI) (Reiss, 
Peterson, Gursky, & McNally, 1986) and Sheehan Disability Scale (SDS) (Leon, 
Olfson, Portera, Farber, & Sheehan, 1997). Information on current work- and/or sick 
leave-status was obtained in the interview, along with information on duration of PD, 
history of psychiatric- and/or somatic illness, and current medication. All outcome 
measures were administered during the clinical interview by a psychiatrist at pre- and 
post-treatment, as well as after a 6-months follow-up period. The psychiatrists doing 
the clinical interviews were not informed of treatment status and were thus blind to 
treatment condition. 
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The treatment programme consisted of 10 self-help modules which were based on 
established CBT principles (see Study III). In the Internet treatment the self-help 
programme was administered via web pages. The group treatment was led by two 
clinical psychologists and also included the same self-help programme, in the form of 
printed handouts. In the Internet treatment, access to the next module was given when 
the clinical psychologist had received the answers to home-work assignments and 
provided feedback. In the group treatment condition, the groups met with the 2 
psychologists during weekly 2-hour sessions. The psychologists involved in the 
treatment were regular staff psychologists not specially trained for participation in the 
trial.  
 
The power for the within-group contrasts were estimated based on a conservative effect 
size of d=0.80, and the sample sizes in each group were regarded as sufficient to detect 
a within-group effect of this size. Given the previous literature on the effects of CBT 
for panic disorder we considered a mean standardized difference at or below d= 0.20 as 
the criteria for equivalence for the main outcome measure PDSS. This is in line with 
previous psychotherapy research in which d=0.20 is regarded as a minor difference of 
little clinical importance. We also calculated 95% confidence intervals for the between 
group effect size. However, we were not able to power the study for the reliable 
detection of a small between group effect. The obtained power was only robust for a 
large difference of d=0.50 (two-tailed test, power 75%), which was well above our 
criteria of equivalence.  
 
The outcome of this trial is not only the between group difference, but also the within-
group effects for the two treatments. For these within-group comparisons missing data-
points are more critical as effects could be overestimated. A number of patients did not 
return for the clinical interview at post-treatment or follow-up. A mixed effects models 
approach was used in the statistical analysis, to adjust for these missing values 
(Gueorguieva & Krystal, 2004). 
 
Cost-effectiveness ratios were estimated by dividing the treatment cost with the 
treatment outcome. In addition, incremental cost-effectiveness was determined using a 
regression framework with costs and effects as dependent variables. All participants 
who attended at least one Internet- or group session were included in the analysis 
(n=104). 
2.4.3 Results 
The between group effect size for the main outcome measure PDSS was d=0.00 
(CI95%=-0.41 to 0.41) at post-treatment whereas the between group effect size at 6-
month follow-up was d=0.23 (CI95%=-0.15 to 0.62). A majority of patients responded 
to treatment, when response was defined as a 40% decrease in PDSS scores from pre- 
to post-treatment and from pre-treatment to follow-up. This was also the case for the 
CGI and status of PD diagnosis. Dropouts (those patients who refused the post-
treatment and/or follow-up interview) were regarded as non-responders. 
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The mixed effect models clearly show that both treatments had significant impact on all 
outcome measures over time. However, there were no interactions or differences in 
estimated means. Hence, both treatments led to statistically significant improvements 
and were not different according to the mixed effect model accounting for missing data. 
 
The average number of weekly modules completed in the Internet treatment was 6.7 
(SD=2.5). The total number of e-mails sent by the therapists during treatment was 555 
(mean per patient: 11.3, SD=4.3). The total average therapist time spent per patient in 
the Internet treatment was 35.4 minutes (SD=19.0). The average number of weekly 
group sessions attended in the group treatment was 8.1 (SD=2.1). The total average 
therapist time spent per patient in the group treatment was 6 hours. 
 
The direct cost of the Internet treatment (therapist time and the cost of psychiatrist 
evaluation) was on average 86 Euros per patient whereas it was 325 Euros for the 
group treatment. Defining effect as proportion of PDSS responders, the cost-
effectiveness analysis showed that Internet treatment had superior cost-effectiveness 
ratios in relation to group treatment both at post-treatment and follow-up. The direct 
cost of treatment for each additional PDSS responder was at post-treatment 516 Euros 
for group treatment and 143 Euros for Internet treatment. At follow up, this cost was 
500 Euros and 121 Euros respectively. 
2.4.4 Discussion 
This study provides evidence for the effectiveness of Internet CBT in a psychiatric 
setting for referred patients with panic disorder, and suggests that it is not less effective 
than the more widely used group administered CBT. Both treatments showed large 
within group effect sizes both at post-treatment and at 6-month follow-up on primary as 
well as secondary outcome measures. In addition, Internet CBT was more cost-
effective than group CBT with respect to direct costs in terms of therapist time. 
 
A majority of patients were considered as responders to treatment, both when this was 
defined as a significant drop in panic symptoms as well as when defined as degree of 
global improvement and end-state functioning. Moreover, a majority of patients no 
longer fulfilled DSM-IV criteria of panic disorder after treatment, and this proportion 
of patients increased somewhat at the 6-month follow-up. 
 
Given low statistical power for detecting a reliable difference between the two 
treatments, equivalence between Internet and group CBT for panic disorder cannot be 
confidently established. However, overall the data suggest that more than half in each 
group responded to treatment with a substantial decrease in symptoms. 
 
To our knowledge this was the first study comparing Internet administered CBT with 
group CBT with referred patients in a regular psychiatric setting. The results from this 
trial provides support for the continued use and dissemination of Internet treatment for 
panic disorder within psychiatry and suggests that this novel treatment medium has the 
potential to greatly increase access to evidence based psychological treatments within 
the health care system. 
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3 GENERAL DISCUSSION 
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3.1 MAIN FINDINGS 
This thesis provides evidence that Internet-based CBT (self-help guided by brief e-mail 
contact) is effective in the treatment of symptoms of depression and panic disorder. 
Internet-based CBT is as effective as traditionally administered group CBT for PD in a 
regular care setting with patients referred for treatment but considerably more cost-
effective. 
 
Study I showed that Internet-based CBT was an effective treatment in reducing 
symptoms of depression in 85 participants with mild to moderate depression. 
Compared to a control condition with an online discussion group, the Internet treatment 
showed large between group effect sizes at post-treatment (Cohen’s d=0.94 for the BDI 
and d=0.79 for the MADRS-S) and improvement was sustained at the 6-month follow-
up. Study I can be said to have been replicated by subsequent trials by our group 
(Holländare, Johnsson, et al., 2010; Vernmark, et al., 2010) as well as independently 
replicated by an Australian research group in a study reviewed earlier (Perini, et al., 
2009). Apart from the fact that no follow-up measurement was made in this Australian 
trial, its design was virtually identical to the design of Study I. Results were also 
similar, with a within-group effect size on the BDI of Cohen’s d=1.15 (Australian trial) 
and d=1.22 (Study I), and a between-group effect size on the same measure of d=0.63 
(Australian trial) and 0.94 (Study I) respectively. If this latter observation might 
indicate that Australian trial was somewhat less successful in depressive symptom 
reduction, this may be due to the fact that it included a more depressed sample. 
 
Study I, being an early trial, preceded many of the studies on Internet treatments for 
depression reviewed earlier in this thesis. Included in the meta-analysis by Andersson 
and Cuijpers (2009a), Study I shows larger effect sizes than many of the other non-
guided trials therein. Later trials that have showed equally large effect sizes have 
underscored the importance of therapist guidance for effective Internet treatment, or, as 
in the trial by Spek and co-workers (2007), if not guided, the importance of clear 
treatment structure and deadline (Andersson, Carlbring, Berger, Almlöv, & Cuijpers, 
2009).  
 
Study II analysed predictors of treatment outcome at the 6-month follow-up of Study I. 
Higher self-reported severity was associated with poorer outcome and a negative 
correlation was found between number of previous episodes of depression and 
improvement in treatment. However, the negative correlation between previous number 
of episodes (M=1.9, SD=1.4) and change score (pre-treatment to follow-up) was weak, 
and only statistically significant for the BDI change score (r= –0.26, p < .05) and not 
for the MADRS-S change score (r= –0.19). Demographic variables such as education 
level and gender showed no relation to treatment outcome. These results are largely in 
contradiction with a later trial investigating predictors of outcome in Internet CBT for 
depression (Spek, Nyklicek, et al., 2008) who concluded that the number of previous 
depressive episodes did not predict poorer outcome, whereas sex of participants and 
education level did; women and those with higher education profiting more from 
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treatment. However, as Spek and co-workers points out, their results are rather in 
contraction with most previous prediction research on traditionally administered CBT 
(Hamilton & Dobson, 2002; Jarrett, Eaves, Grannemann, & Rush, 1991). The fact that 
we in Study II did not find a relation between education level and outcome can 
however be due to a restriction of range effect, since those participating in an Internet 
treatment may be a more highly educated group as a whole. In sum, with the present 
evidence, it is difficult to draw firm conclusions about reliable pre-treatment predictors 
of outcome in Internet treatment. Thus there are relatively few robust predictors of 
treatment outcome in psychological treatment generally and in guided self-help 
specifically. The genetic research by our group (Lonsdorf, et al., 2010) however 
tentatively suggest that this may be a fruitful and yet not well explored research area in 
which future research could give important information.  
 
Study III showed that Internet-based CBT was effective within a regular psychiatric 
setting for 20 PD patients referred for treatment. After treatment 75% of patients were 
considered to have responded to treatment, and at 6-month follow-up this proportion 
was 70%. Even though being a small trial, it was important as a feasibility study, 
showing for the first time that Internet treatment was very well integrated within 
psychiatric care, organisationally as well as technically, and that it was well accepted 
by staff as well as patients. 
 
Study IV, building upon the experiences from Study III, was a large trial including 104 
patients predominantly referred for treatment which showed that Internet-based CBT 
was equally effective as group-administered CBT within a psychiatric setting. There 
were no statistically significant differences between the two at post-treatment or at the 
6-month follow up. It also evaluated the relative cost-effectiveness of these two 
treatments, an analysis that showed Internet treatment to be considerably more cost-
effective than group treatment with regard to therapist time.  
 
The trials in this thesis have of course several limitations that previously have been 
discussed separately for each study. 
3.2 THERAPIST- AND CLIENT FACTORS AND THE 
THERAPEUTIC RELATIONSHIP 
In the studies in this thesis, the self-help programmes were thus accompanied by 
obligatory therapist contact. The relative influence of the quality and/or amount of 
therapist assistance was however not studied.  
 
As reviewed earlier, research suggests that treatment structure (with clear “deadline”) 
and guidance are probably crucial elements for guided self-help to be effective (Nordin, 
et al., 2010; Palmqvist, et al., 2007; Spek, Cuijpers, et al., 2007). In trials for both 
depression and PD evaluating “open” self-help sites with no or poor diagnostic 
assessment nor defined structure or therapist support, clinical efficacy is more uncertain 
and the attrition rate us usually very high (Andersson, et al., 2009). In one such trial on 
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PD (Farvolden, Denisoff, Selby, Bagby, & Rudy, 2005) only 1% (sic) of participants 
completed the proposed self-help modules. As discussed previously, in our Swedish 
group, special attention has been devoted to these issues (Andersson, Bergström, et al., 
2008).  
 
However, it seems that one does not necessarily gain treatment effect by increasing 
therapist time or involvement over a certain (minimal) threshold. In one study on PD it 
was shown that increasing therapist contact (from 1 to 3 weekly contacts) did not 
significantly enhance treatment effect (Klein, et al., 2009). Similar conclusions may be 
drawn from the study on depression by our group previously discussed (Vernmark, et 
al., 2010) where a substantial increase in therapist contact did not enhance efficacy. In 
the studies in this thesis, as well as in most studies of Internet-based guided self-help 
treatment, the patient’s contact with the therapist has consisted of weekly, 
approximately 10 minute long, interactions. This may very well represent the minimal 
therapist involvement necessary. However, the threshold or “breaking point” 
(Palmqvist, et al., 2007) of what constitutes the optimal amount of therapist contact for 
an effective guided self-help is again not known and future research is warranted here. 
This threshold is reasonably different between different diagnoses and most probably 
also depends of the extent of the treatment programme and the amount of interactive 
supportive functions built into it.  
 
In psychotherapy research, one is of course not only interested in the quantity but also 
the quality of therapist contact. It is often stated that this therapeutic relationship is 
central to understanding the effects of therapy (Wampold, 2001). It is however an area 
of research not extensively developed and where relatively little is yet known about 
which therapist variables that are particularly important for effective therapy (Beutler, 
et al., 2003). The influence of individual therapist effects has been specifically studied 
in Internet-based treatment for depression (Almlöv, Carlbring, Berger, Cuijpers, & 
Andersson, 2009). The results of the study made the authors suggest that self-help 
based treatments are probably less sensitive to therapist effects when it comes to those 
themes directly focused upon in the self-help programme (in this case depressive 
symptoms) whereas it may play a role when it comes to areas not directly addressed 
(such as quality of life issues). It is possible that different therapist characteristics, even 
in Internet treatment, are more or less appropriate for different patient groups 
(diagnosis) and individuals.  
 
One factor of the individual client that has been proposed to influence outcome of 
treatment is which preference he or she has for which treatment. In a large study on 
CBT and pharmacological treatment for (chronic) depression, it was shown that 
treatment preference was a potent moderator of treatment response for both CBT and 
pharmacological treatment respectively (Kocsis, et al., 2009). This should be studied 
more closely within the field of Internet-based treatment. 
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3.3 NEGATIVE EFFECTS AND POSSIBLE RISKS  
Psychotherapy research in general, and maybe CBT research in particular rarely 
includes structured analyses of negative effects (Barlow, 2010). A possible specific risk 
with treatments based on self-help that has been evoked (Taylor, 2000) is that they 
would constitute suboptimal treatments who would leave participants not responding 
hopeless about the possibility of improvement, and that they thus would not seek 
subsequent, possibly more effective traditionally administered treatment. There is 
however no empirical evidence that the risk of negative effects would be greater in 
guided self-help than in traditional treatment (Scogin, et al., 1996). Nevertheless, these 
issues should be studied more closely in future research. 
3.4 INTERNET TREATMENT AND PSYCHOTHERAPY 
One could argue that the development of guided self-help treatments poses interesting 
questions concerning the very definition of what should be considered to be a 
“psychological treatment” or “psychotherapy” and how research on them should be 
pursued. Up until now, no distinction has been made in this thesis between these terms. 
Renowned CBT researcher David H. Barlow has proposed (2004) that the term 
psychological treatment should be reserved for evidence-based treatments for discrete 
medical conditions, whereas psychotherapy would be a broader term including generic 
therapy not necessarily of discretely diagnosed conditions nor with established efficacy.  
 
So what is then Internet treatment? As Andersson and Cuijpers (2009b) have proposed, 
it is probably best defined as a psychological treatment. However, Barlow does not 
necessarily distinguish between guided and non-guided interventions. In my view, pure 
(un-guided) self-help can best be considered as a prevention programme and thus as a 
question of public health rather than as a treatment. In this view, one of the defining 
features of a treatment is the fact that the client or patient has been assessed by, and is 
guided by, a professional who also engages in treatment, by giving at least some 
feedback or homework etc.  
 
As stressed throughout this thesis, it evaluated guided self-help, and with this little 
word “guided” one thus leaves the area of prevention and pure self-help and one enters 
the domain of treatment- and psychotherapy research. By doing so one inevitably and 
fairly quickly encounters several challenges, pertaining to basic issues of what 
constitutes a “psychological treatment” or “psychotherapy”, as evoked by Barlow, but 
also much more basic and profound issues of theories of science and methodology. 
 
The fact that this thesis evaluated specific, manualised psychological treatments for 
discretely diagnosed psychiatric disorders by means of quantitative symptom 
measurement in an experimental design using randomised controlled trials (RCTs), 
already inscribes it in a medical or experimental tradition that many psychotherapists 
and researchers have judged inadequate or misleading (Freire, 2006; Sandell, 1987; 
Wampold, 2001).  
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Such a research design is closely linked to the definition of what constitutes an 
empirically supported treatment (EST) and has, during the last 20 years, been 
increasingly in focus within the field of psychotherapy research (Chambless & Hollon, 
1998). This is in part inspired by medical research and evidence-based medicine 
(Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). This development has gone 
hand in hand with evolving managed care policies and the development of clinical 
practice guidelines. Those who criticise this development either discard it as a whole, 
claiming that the methods used in EST research (as well as its underlying philosophy of 
science), like RCTs, are not at all relevant for understanding or studying 
psychotherapy, or they acknowledge the great merit of these methods, but hold that the 
exclusive focus on RCTs is not sufficient and leaves many important questions 
unanswered (Barlow, 1996; Garfield, 1998).  
 
One of the concerns expressed is that, unlike many pharmacological treatments, the 
mechanisms of action of ESTs are often not well understood and that exclusive focus 
on RCT-evaluation of broad “treatment packages” abandons important research in 
understanding psychological mechanisms of action. The Internet treatments evaluated 
in this thesis are in this sense typical examples of EST research that does not elucidate 
the mechanisms of action of behaviour- and cognitive therapy outlined in the 
introduction. There is thus a need for component analyses (Jacobson, et al., 1996) 
within this area, a type of research design for which Internet treatment could lend itself 
well, because of the modular structure of most self-help programmes. 
 
Another major concern evoked in psychotherapy research relates to the transferability 
of highly structured EST protocols into clinical practice, thus highlighting effectiveness 
(as opposed to efficacy) research (Barlow, 1996; Hunsley & Lee, 2007), an issue that 
was taken into account in Study III and IV.  
 
It is also worth pointing out that, even if much EST research shares methodological 
practices with the medical tradition, it may often not share a medical perspective when 
it comes to the diagnostics or the aetiology of psychiatric disorders (Andersson & 
Ghaderi, 2006). One example is the view taken by researchers within the behavioural 
tradition arguing that depression should be “de-medicalised” (Jacobson & Gortner, 
2000). 
 
The differences between various forms of psychotherapy apparent in the research 
literature as for their empirical status as reviewed previously in this thesis can only be 
understood in the light of the questions raised above. An example is psychoanalytic 
therapy which, although a highly practised form of psychotherapy in clinical 
psychiatric settings, is most often scarcely represented in records of ESTs for the most 
common psychiatric conditions, especially anxiety disorders (Chambless & Ollendick, 
2001). Certain researchers within this tradition claim that methods used in EST 
research are difficult or impossible to apply to psychoanalytically oriented therapies 
(Leichsenring, 2005). However, other psychotherapy researchers within the 
psychoanalytic tradition do now argue that such treatments actually can and should be 
evaluated by methods consistent with EST principles (Busch, Milrod, & Sandberg, 
2009). 
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Internet treatment based on a psychoanalytically informed self-help book (Silverberg, 
2005) has in fact been evaluated in one study for generalised anxiety disorder (GAD) 
(Paxling, et al., 2009). In this still unpublished trial 81 participants with GAD were 
randomised to Internet-based CBT, Internet-based psychoanalytic treatment, or an 
untreated control condition. No significant differences were found between the active 
treatments neither at post-treatment nor at follow-up. However, in this trial the control 
condition improved significantly as well, leaving the study difficult to interpret. 
 
Another development within research on Internet treatment has been to evaluate the 
possibility of tailoring treatment to individual client needs, that is to let the treatment 
content depend more one individual therapist judgement of what is appropriate for the 
individual client. This has been done not only be evaluating “e-mail therapy” as 
mentioned previously (Vernmark, et al., 2010) but also by doing “tailored guided self-
help” evaluated in two still unpublished studies on Internet CBT for anxiety and 
depression (Carlbring, et al., 2007; Johansson, 2009). In this approach the therapist 
chooses, based on client symptomatology, which self-help modules that are to be used 
as well as their sequence. These studies tentatively suggest that this form of Internet 
treatment is no less effective but possibly more clinically flexible than the “fixed” 
Internet CBT treatments used up until now, like those evaluated in this thesis.  
 
Summing up, the field of Internet-based treatment is now, as is the field of 
psychological treatment as a whole, incorporating more issues and methods 
traditionally used in psychotherapy research an is thus expanding what up until recently 
has rather been an exclusive focus on EST research.  
3.5 CLINICAL IMPLICATIONS 
In the very first National guidelines for the treatment of depression and anxiety 
disorders recently published by the Swedish National Board of Health and Welfare 
(2010), the implementation of Internet-based CBT is recommended for the treatment of 
both depression and PD. 
 
As a consequence of the studies in this thesis, its treatments for depression and PD are 
now implemented within the Stockholm County Council, making Internet CBT 
accessible for all potential patients with these diagnoses in the region. This probably 
makes Stockholm County Council the first public health care service in the world to 
offer Internet-based psychological treatment to their citizens within regular psychiatric 
care. Up until now, several hundreds of patients have been treated in this way at the 
unit of Internetpsykiatri.se at Psychiatry Southwest.  
 
It is possible that Internet treatment, precisely by increasing access to empirically 
supported psychological treatment, may actually change the public perception of what 
psychotherapy is. Rather than being perceived as something obscure and exclusive, it 
may become something transparent and accessible. That would be, I think, a good 
thing. 
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